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ABSTRACT 
  
Massive glycerol cluster ions with many charges (~ 10
6
 Da, ~ ±100 charges) have been 
generated by electrospray to bombard biomolecules and biological sample surfaces. The 
low impact energy per nucleon facilitates intact sputtering and ionization of biomolecules 
which can be subsequently imaged. Various lipids, peptides and proteins have been 
studied. The primary cluster ion source has been coupled with an ion-microscope 
imaging mass spectrometer (TRIFT-1, Physical Electronics). A lateral resolution of 
~3µm has been demonstrated, which is acceptable for sub-cellular imaging of animal 
cells (e.g. single cancer cell imaging in early diagnosis). Since the available amount of 
target molecules per pixel is limited in biological samples, the measurement of useful ion 
yields (ratio of detected molecular ion counts to the sample molecules sputtered) is 
important to determine whether enough ion counts per pixel can be obtained. The useful 
ion yields of several lipids and peptides are in the 1-3×10
-5
 range. A 3×3 µm
2
lipid bilayer 
can produce ~260 counts/pixel for a meaningful 3×3 µm
2
 pixel ion image. This method 
can probably be used in cell imaging in the future, when there is a change in the lipid 
contents of the cell membrane (e.g. cancer cells vs. normal cells).  
 ii 
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CHAPTER 1 
INTRODUCTION TO IMAGING MASS SPECTROMETRY 
Imaging of biological structures in the past centuries has enhanced our 
understanding of the biological world. Optical microscopy allowed the discovery of cells 
(Robert Hooke 1665) which are the basic units for living organisms. This is still one of 
the most popular bioimaging methods nowadays. The introduction of fluorescence 
microscopy allowed localization of target molecules inside the biological structure 
(Ghiran 2011). Common fluorescent labeling strategies include small molecule staining 
(DAPI for DNA (Kapuscinski 1995)), fluorescent antibodies (Kawamura 1969) and green 
fluorescent protein (GFP) (Ormo et al. 1996). Confocal laser scanning microscopy 
(CLSM) provides 3D high resolution optical images (Cremer and Cremer 1978). Electron 
microscopy uses an electron beam instead of light. Because the wavelength of the 
electron is much shorter than that of light photons, it can resolve structures smaller than 
one nanometer (Erni et al. 2009) producing spectacular images of cells. But these two 
bioimaging methods exhibit a limitation that they are blind to molecular information 
without labeling. In optical microscopy, target molecules can be labeled with fluorescent 
tags in order to be visible. In electron microscopy, immunogold labeling (Faulk 1971)or 
staining is used to locate specific target biomolecules.  
 
1.1 Immunohistochemistry 
Immunohistochemistry is a well-established method in disease diagnosis, drug 
development and biological research. Antibodies are used to detect antigens (e.g. proteins) 
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through their specific binding in a tissue sample. In order to visualize the antibody-
antigen interaction, fluorophores or enzymes are added to the antibody.  
The general process of immunohistochemistry involves: tissue collection (e.g. 
biopsy); tissue fixation (e.g. formaldehyde); tissue embedding (e.g. paraffin); sectioning 
and mounting; epitope recovery; blocking nonspecific sites; sample labeling; sample 
visualization through optical microscope;  morphological information; pathological 
diagnosis (Overview of Immunohistochemistry, Life Technologies, Thermo Fisher 
Scientific Inc.).  
 Due to the light wavelength, the best spatial resolution for an optical microscope 
is limited to ~ 200 nm. But this resolution is enough to produce spectacular images of 
cells (prokaryotes ~1-5 µm and eukaryotes ~10-30 µm). Usage of fluorescence or 
enzymatic amplification makes this method highly sensitive. Both of these two merits 
make it a widely used technology. 
 Immunohistochemistry has been studied extensively using tags (e.g. antibody) for 
cancer diagnosis. For example, Wei Huang at University of Wisconsin-Madison found 
that the expression of Spermidine/Spermine N1-Acetyl Transferase (SSAT) and the 
enzyme protein in human prostate cancer (PCa) is related to the cancer progression and 
metastasis(Huang et al. 2015). Two tissue microarrays (TMA) were used for the 
verification: progression TMA (pTMA) and outcome TMA (oTMA) (tissues were 
collected from 1999 to 2005 and followed until 2015 for disease outcome). The pTMA 
includes benign prostate hyperplasia (BPH), benign prostate tissues (BPT), high-grade 
intraepithelial neoplasia (HGPIN), localized PCa (PCa_local), aggressive PCa (PCa_aggr) 
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and metastatic PCa (Met). The oTMA includes none recurrence, biochemical recurrence 
and cancer recurrence (local or distant). Figure 1 shows the increased expression level of 
SSAT mRNA and SSAT protein from noncancerous to cancerous tissues and from no 
recurrence to cancer recurrence. The SSAT mRNA and SSAT protein might serve as a 
biomarker for prostate cancer grading and prognosis.  
 
Figure 1. (a), normal epithelium sample by H&E; (b):  normal epithelium tissue stained 
by RNA-ISH for SSAT mRNA; (c): patient biopsy tissue containing PCa stained by H&E; 
(d): patient biopsy tissue containing PCa stained by RNA-ISH for SSAT mRNA; (e): 
benign prostate tissue (BPT) stained by anti-SSAT antibody for SSAT enzyme protein; 
(f): prostate cancer tissue stained by anti-SSAT antibody for SSAT enzyme protein. (g): 
expression level of SSAT mRNA and SSAT protein increases from BPT (benign prostate 
tissue) to metastatic PCa; (h): expression level SSAT mRNA and SSAT protein increases 
from no recurrence to cancer recurrence samples. Reprinted with permission from Huang 
et al. (2015), Copyright 2015 Wiley Periodicals, Inc. 
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Although immunohistochemistry is widely used in disease diagnosis and 
biological research, it still has several limitations. For example, (1): it requires prior 
knowledge of the biomarker. The right antibody can be chosen only after the antigen is 
clearly known; (2): the antibody is expensive (a few hundred dollar at microgram); (3): in 
a single measurement, only one or several target molecules can be labeled; (4): lipid 
changes have been demonstrated to be associated with many diseases (e.g. cancer), but 
immunohistochemistry is not well-suited to image lipids; (5): complicated sample 
processing in immunohistochemistry makes the measurement time long (hours to days).  
 
1.2 Imaging Mass Spectrometry 
Imaging mass spectrometry (IMS), a technique derived from mass spectrometry, 
can provide a solution to the problems discussed above. The mechanism of IMS is 
different from immunohistochemistry. In mass spectrometry, molecules in a sample 
tissue are ejected as ions into the gas phase and extracted into a mass analyzer. The 
mass/charge ratios of the sample molecular ions are measured by magnetic or time of 
flight mass spectrometry. Moreover, tandem mass spectrometry can provide structural 
information of the molecules by fragmenting the parent molecules. In this way, sample 
molecules can be identified without the help of labeling. In imaging mass spectrometry, 
the spatial distribution of target molecules can be revealed by ejecting them with a 
spatially focused beam of photons or ions or using a microscope ion imaging mass 
spectrometer. 
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Advantages of IMS are: (1): tag (e.g. antibody) free; (2): simultaneous 
acquisition/imaging of many species; (3): potential biomarker discovery through the 
whole spectrum imaging; (4): well-suited for lipid imaging. Details are explained below.  
 
1.2.1 MALDI Imaging 
A typical MALDI (Matrix-Assisted Laser Desorption/Ionization) imaging mass 
spectrometry process is illustrated by Caprioli et al. (Stoeckli et al. 2001)at Figure 2 
(reprinted with permission from Stoeckli et al. (2001), Copyright 2001 Nature Publishing 
Group). A section of frozen brain tissue was placed on a metal target. The tissue sample 
was coated with a MALDI matrix solution. The sample molecules are dissolved into a 
matrix solution. When the solution is being dried, the sample molecules co-crystallize 
with the matrix molecules. A pulsed laser beam is used to irradiate the sample surface, 
spot by spot. When the matrix molecules absorb photons from the laser beam, they 
become superhot and a small volume of the matrix explodes (Chou, Nelson, and 
Williams 2009). The explosion process ejects the ionized sample molecules into the gas 
phase. From each spot, a full spectrum was displayed with various molecular peaks. 
When a specific peak was chosen, its distribution inside the brain tissue was obtained. 
MALDI can eject intact molecular ions up to one MDa (Nelson, Dogruel, and Williams 
1994). The invention of MALDI has a huge impact on the way people do imaging mass 
spectrometry of biological samples. Imaging of lipids (Chughtai et al. 2013), peptides 
(Cillero-Pastor et al. 2013; Stauber et al. 2010), proteins (Chaurand et al. 2008) in tissue 
samples has been done. 
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Figure 2. MALDI imaging process of a frozen brain tissue sample (Stoeckli et al. 2001). 
The surface of a sliced frozen brain tissue was coated with matrix solution. Scanning of 
laser beam on the surface revealed the distribution of molecules for each peak. Reprinted 
with permission from Stoeckli et al. (2001), Copyright 2001 Nature Publishing Group. 
 
Professor Richard M. Caprioli at Vanderbilt University has done extensive 
research using MALDI imaging for biomarker discovery, disease diagnosis, proteomics 
and so on. An example of MALDI imaging in biomarker discovery was shown by 
Caprioli et al. (Chaurand, Schwartz, and Caprioli 2004) (Figure 3). A mouse brain tissue 
sample with a tumor section and normal section adjacent was tested by MALDI imaging. 
Imaging of many ion species simultaneously shows preferred distribution of some ions 
either in the tumor region or the normal region. For example, m/z 6924, 9910 (acyl coA-
binding protein), 11,307 and 11,348 (histone H4), 13,804 and 15,350 (histones H2B1 and 
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H3) and m/z 24,807 are concentrated in the tumor region. These molecules maybe can 
serve as potential biomarkers for the mouse brain tumor.  
 
Figure 3. MALDI imaging of a mouse brain tissue with a tumor section and normal 
section adjacent. (A): Optical image of the mouse brain with the tumor area circled by red 
dots; (B-L): ion images of various m/z species. Some ions distribution are associated with 
the tumor specifically. These ions might serve as potential biomarker for the mouse brain 
tumor.  Imaging resolution is ~110 µm. Reprinted with permission from Chaurand, 
Schwartz, and Caprioli (2004), Copyright 2004 American Chemical Society. 
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Imaging mass spectrometry has also been demonstrated to be successful using cell 
lipids. There are several reasons for this. First, the cell membrane lipids are abundant 
compared with proteins inside the cells. Second, the lipids are located at the outside 
surface of cells making them easily accessible for imaging. Third, lipid molecules are 
readily ionized including a phosphate and a quaternary ammonium center. All of these 
reasons make lipid a good target for imaging mass spectrometry. Various studies have 
shown that there is dramatic lipid changes in cancer cells compared with normal cells. 
For example, Shimma et al. (Shimma et al. 2007) demonstrated abnormal phospholipids 
distribution in human colon cancer liver metastasis (Figure 4). An increased expression 
of lipid at m/z 725.5 and a decreased expression of lipid at m/z 616.1 were observed in 
the cancer region compared with the normal region.    
 
Figure 4. (a). Optical image of a H&E stained tissue sample obtained from a patient with 
colon cancer liver metastasis; (b): MALDI spectrum and ion image of m/z 725.5 show an 
increased expression in cancer region; (c): MALDI spectrum and ion image of m/z 616.1 
show a decreased expression in cancer region. Reprinted with permission from Shimma 
et al. (2007), Copyright 2007 Elsevier B.V. 
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 Guo et al. did MALDI imaging of cancer tissues and normal tissues for six 
different types of human cancers (thyroid cancer, gastric cancer, lung cancer, esophageal 
cancer, colorectal cancer and breast cancer) (Guo et al. 2014). Expression was different 
for various lipids between the cancer tissues and normal tissues (Figure 5).  
 
Figure 5. Top: Optical images of H&E stained tissue (red dots represented cancerous area, 
blue dots represented normal area). Lower: Dramatic differences for various lipids (PC: 
phosphatidylcholine, PA: phosphatidic acid) with different cancer tissue samples were 
observed by MALDI imaging. Spatial resolution was 200 µm. Reprinted with permission 
from Guo et al. (2014).  
 
A direct comparison of H&E stained optical image and a MALDI image was 
demonstrated by Caprioli (Caprioli 2015). Figure 6 displays an optical image of a 
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transverse section of mouse brain (stained with hematoxylin/eosin) (left side) and an ion 
image of a lipid PI (38:4) (m/z 885.6) (right side). The lipid ion image provides another 
type of vision into the tissue sample compared with the H&E stained optical image. The 
scale bar is 1 mm. The ion image acquisition time is 35 hours.  
 
Figure 6. (left): optical image of a mouse brain section; (right): ion image of PI(38:4) 
(m/z 885.6). Spatial resolution is ~15 µm. Scale bar is 1 mm. The acquisition time for the 
ion image is 35 hours (0.35s/pixel, 364,740 pixels). Reprinted with permission from 
Caprioli (2015), Copyright 2015 American Society for Mass Spectrometry.  
 
Higher spatial resolution (smaller laser spot diameter ~1 µm) MALDI imaging for 
proteins has been performed by Caprioli et al. (Zavalin et al. 2015) (Figure 7).   
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Figure 7. MALDI imaging of mouse cerebellum with 1µm laser spot diameter. Red color 
represents m/z 14127 (myelin basic proteins); green color represents m/z 13804 (histone 
H2B); blue color represents m/z 11347 (histone H4). The scale bar is 100 µm. Reprinted 
with permission from Zavalin et al. (2015), Copyright 2015 Springer. 
 
There are several limitations for MALDI imaging described above: (1): long 
imaging time, the ion image is formed by rastering a focused laser beam on the sample 
surface pixel by pixel; (2): matrix smear effect, the sample molecules need to be 
dissolved into the matrix solution then re-crystallized, thus they can move away from 
their original positions in the solution. The smear effect limits spatial resolution to ~10 
µm (Passarelli et al. 2014) (Figure 8).  A patterned sample with alternated PEG and lipid 
stripes was used to test the matrix smear effect. Migration of PEG and lipid molecules 
from their original position has been observed.  
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Figure 8. Matrix smear effect test. A test device with alternated stripe of polyethylene 
glycol (PEG) (blue color) and PC(16:0/16:0) (green color) was analyzed by TOF-SIMS 
with Bi3
+
 primary ion beam. After the application of a MALDI matrix (DHB), migration 
of PEG and lipid molecules are observed. The average migration distance of lipid and 
PEG is ~16 µm and ~6 µm accordingly. Reprinted with permission from Passarelli et al. 
(2014), Copyright 2014 American Chemical Society.  
 
1.2.2 DESI Imaging 
Desorption Electrospray Ionization is another popular imaging mass spectrometry 
method which uses electrospray in atmosphere to splash the sample surface. One major 
advantage for this method is that it can do ambient desorption and ionization. Samples do 
not need to be loaded into vacuum. This method can provide in situ analysis (e.g. 
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physician can use it to determine the boundary of cancer and normal tissue while 
removing the cancer tissue in a surgery).  
The imaging is realized through scanning an electrospray ion beam on sample 
surface. First, the sample surface becomes coated with the electrospray solution in which 
the molecules at the surface can dissolve. Then, subsequent droplet impacts can splash 
the dissolved sample molecules into the gas phase. The splashed droplets are drawn into a 
mass spectrometer and heated to evaporate the solvent and produce free molecular ions. 
The intact mass range can go up to 66 kDa (Venter, Nefliu, and Cooks 2008). DESI has 
been used for imaging of lipids (Venter, Nefliu, and Graham Cooks 2008; Girod et al. 
2010; Eberlin, Ferreira, et al. 2011; Eberlin, Liu, et al. 2011; Ellis et al. 2010) and 
peptides (Eberlin, Liu, et al. 2011) in tissue samples. Various applications have been 
developed for DESI. Some typical applications are listed below (Dill et al. 2011) (Figure 
9) including cancer diagnosis (e.g. biomarker discovery), forensic analysis, drug 
discovery and so on. 
 
Figure 9. Applications of DESI include cancer grading, 3D molecular images, drug 
mapping, tumor diagnostics, chemical fingerprint and analysis of inks. Reprinted with 
permission from Dill et al. (2011), Copyright 2011 The Royal Society of Chemistry.  
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Graham Cooks and his colleagues at Purdue University demonstrated dramatic 
lipid pattern differences between the human papillary renal cancer tissues and normal 
tissues using DESI (Figure 10) (Eberlin, Ferreira, et al. 2011; Eberlin et al. 2012). Spatial 
resolution was low but the image contrast was high. 
 
Figure 10. In human papillary renal cell carcinoma, a higher expression of lipid PI 
(Phosphatidylinositol) (18:0/20:4) (m/z 885.7) was observed compared with normal 
tissue by DESI imaging. A lower expression of seminolipid (16:0/16:0) (m/z 795.4) was 
observed in human germ cell seminoma compared with normal tissue. Reprinted with 
permission from Eberlin et al. (2011), Copyright 2011 Elsevier B.V. 
 
One limitation of DESI is the imaging resolution. It is difficult to focus an 
electrospray beam in atmosphere. The lateral resolution is ~200 µm which is not enough 
for sub-cellular imaging (Venter, Nefliu, and Graham Cooks 2008).Attempts have been 
made to improve the DESI spatial resolution. One example is to shrink the capillary 
  15 
diameter. Laskin et al. used Nanospray to do ambient desorption and ionization. The 
spatial resolution achieved is ~10 µm (Laskin et al. 2012) (Figure 11). 
 
 
Figure 11. Spatial resolution test with nanospray desorption electrospray ionization. (a): 
optical image of a rhodamine grid; (b): higher magnification optical image of 2×2 grids; 
(c):  Ion image of the grids in (b); (d): line scan and plot profile showing a spatial 
resolution ~ 10 µm. Reprinted with permission from Laskin et al. (2012), Copyright 2011 
American Chemical Society.  
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1.2.3 SIMS with Atomic Ion Beam 
In SIMS (secondary ion mass spectrometry), a primary ion beam sputters and 
ionizes sample molecules producing secondary ions (Figure 12). These secondary ions 
are accelerated by an extraction electric field into the mass spectrometer composed of 
electrostatic and magnetic sectors, or a field free drift region. Different m/z ions have 
different trajectories in the magnetic field or different flight time in a field free drift 
region. Through different trajectories or flight time, their mass to charge ratio can be 
measured.  
 
 
 
 
 
Figure 12. Secondary Ion Mass Spectrometry with atomic primary ion beam (e.g. Cs
+
,O
-
). 
Focused primary atomic ion beam is used to raster the sample surface. Ionized sample 
molecules and fragments are sputtered into the gas phase. Extensive surface and in-depth 
fragmentation of sample molecules is produced. 
 
SIMS using atomic primary ions has been studied and developed for more than 50 
years (Castaing and Slodzian 1961). Image resolution of ~50 nm (Slodzian et al. 1992; 
Lechene et al. 2006) has been achieved for NanoSIMS (developed by AMETEK, Inc. - 
CAMECA). The primary ions are usually accelerated to 16 keV. The primary ions with 
Cs
+
, O
-
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high energy density damage the sample molecules extensively and generate mainly 
atomic secondary ions and small fragments, e.g. CN
-
. It is difficult to get intact molecular 
secondary ions larger than a few hundred Da. The applications for this method are mainly 
in semiconductors (Kachan et al. 2004; Kudriavtsev et al. 2011), materials science 
(Thomen, Robert, and Remusat 2014), geology (Badro et al. 2007; Floss et al. 2006) and 
biological research with isotopic labeling (Tanji et al. 2008; Weber et al. 2010; Romer et 
al. 2006).  
Dr. Claude Lechene at Harvard developed the Multi-isotope Imaging Mass 
Spectrometry (MIMS) based on the NanoSIMS from Cameca Inc (France). The 
biological samples are cultured in an isotopically labeled medium. Through the isotope 
enrichment at certain area inside the cell, a quantitative color contrast can be built to 
reveal the features of the cell. One example is to incorporate the cell with 
15
N-thymidine 
(Steinhauser et al. 2012). The 
15
N-thymidine is a material used in the DNA synthesis. So 
it is preferably concentrated inside the cell nucleus. In Figure 13, a fibroblast cell was 
labeled with the 
15
N-thymidine. The left image in Figure 13 is an optical image obtained 
with differential contrast reflection microscopy. The central image is the ion image of 
14
N 
which is the naturally most abundant isotope of nitrogen. The image of the 
15
N/
14
N ratio 
(right) shows the contrast of cell nucleus compared with the rest of the cell (
15
N-
thymidine is concentrated at the nucleus region). The scale bar is 10 µm. 
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Figure 13. (a): Differential interference contrast reflection microscopy image of fibroblast 
cells; (b): Ion image of 
14
N; (c): 
15
N/
14
N ion image shows a color contrast between the 
cell nucleus and the rest of the cell (the color scale represents ratio of 
15
N/
14
N from 0 to 
700). The scale bar is 10 µm. Reprinted with permission from Steinhauser et al. (2012), 
Copyright 2012 Macmillan Publishers Limited.  
 
Another example of high resolution imaging on a biological sample was 
demonstrated by Mary Kraft et al. (Frisz et al. 2013) using the NanoSIMS (Figure 14).  
Sphingolipid and cholesterol in the cell plasma membrane (clone 15 cell line) were 
labeled with 
15
N and 
18
O correspondingly. Through the isotope enrichment (
12
C
15
N
-
/
12
C
14
N
-
 or 
18
O
-
/
16
O
-
 ratio), the cholesterol was found to be evenly distributed in the cell 
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membrane, whereas the distribution of sphingolipid was unevenly (concentrated at 
multiple locations). This experiment demonstrated that cholesterol and sphingolipid are 
not co-localized to form lipid rafts. This is different with prior understanding of the roles 
of sphingolipid and cholesterol in the cell membrane.    
 
Figure 14. (a): SEM image of the cell membrane (clone 15 cell line); (b): 
15
N enrichment 
high resolution image; (c): 
18
O enrichment high resolution image. The evenly distributed 
18
O-cholesterol and unevenly distributed 
15
N-sphingolipids in the plasma membrane of a 
clone 15 cell revealed that sphingolipids and cholesterol are not co-localized in the cell 
membrane to form lipid rafts (Frisz et al. 2013). The scale bar is 2 µm. 
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1.2.4 C60 SIMS 
Another IMS method uses a C60 primary ion beam instead of the atomic primary 
ion beam (Figure 15). Since C60 has a higher molecular weight (720 Da), the energy per 
nucleon (13.9 eV/nucleon with 10 kV) is smaller than for atomic ion beams (e.g. O
- 
625eV/nucleon with 10 kV) with the same acceleration voltage. Smaller energy density 
helps in reducing fragmentation and increasing the survival probability for intact 
molecular ions. C60 SIMS can sputter and ionize intact molecules in the mass range up to 
a few hundred Da, but there is still a significant amount of fragmentation. A spatial 
resolution of  ~250 nm has been achieved (Winograd 2005). C60 SIMS has been used 
broadly in imaging of lipid fragments in biological samples (Ostrowski et al. 2004; 
Piwowar et al. 2013). 
 
Figure 15. Secondary Ion Mass Spectrometry with C60 primary ion beam. Focused C60 
ion beam is used to raster the sample surface. Less fragmentation and higher sputter yield 
are obtained with C60 primary ion beam compared with atomic primary ion beam. 
 
One example of C60 imaging of single cell lipids is demonstrated by Passarelli et 
al. (Passarelli, Ewing, and Winograd 2013) (Figure 16). Intact ions of vitamin E and 
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cholesterol were observed. Fragment ion peaks of phosphocholine were used to 
demonstrate its distribution. The author stated that the parent ions of phosphocholine 
were not enough to allow imaging. The phosphocholine headgroup (m/z 184) appears to 
be the most intense peak for phosphocholine; however this species is not specific for a 
single lipid.  
 
Figure 16. C60 TOF-SIMS imaging of a single aplysia neuron. Ion images of (a): vitamin 
E (m/z 430.3); (b): hydrocarbon (m/z 128.1); (c): cholesterol (m/z 369.3); (d): 
phosphocholine headgroup (m/z 184); (e): PC (15:0 e/18: 1) fragment (m/z 709.6); (f): 
sum of PC related fragment peaks. Scale bar is 100 µm. Reprinted with permission from 
Passarelli, Ewing, and Winograd (2013), Copyright 2013 American Chemical Society.  
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1.2.5 Microscope Ion Imaging  
Based on the way an image is formed, IMS can be divided into microprobe and 
microscope ion imaging (Luxembourg et al. 2004) (Figure 17). In microprobe imaging, 
the primary ion beam is focused and scans the sample surface pixel by pixel. The imaging 
resolution is determined by the size of the focused primary ion beam. In microscope ion 
imaging, the secondary ions coming out of the sample surface store their relative position 
information in the transmission process and are projected back to a mass-resolved image 
of the sample on a position sensitive detector. In this case, the secondary ion optics 
determine the imaging resolution. The majority of the IMS methods used today belong to 
the microprobe ion imaging which has achieved high spatial resolution below micrometer 
which has not demonstrated high spatial resolution for intact molecular species. In 
addition, the imaging time is long (hours or even days) because the primary ion beam is 
rastered on the sample surface pixel by pixel.  
The spatial resolution of microscope ion imaging is limited by spherical and 
chromatic aberrations as in the optical microscope. If sufficient intensity is available in a 
molecular ion signal, a small contrast aperture can limit the spherical aberrations 
allowing sub-micron spatial resolution. For weaker signals, a larger contrast aperture 
must be used which results in resolution of a few micrometers or tens of micrometers.     
Few micrometer resolution is sufficient for sub-cellular imaging of most eukaryotic 
animal cells. Microscope ion imaging provides an option for primary ion beams which 
are difficult to focus. The image acquisition time can be decreased significantly because 
the primary ion beam no longer needs to raster the sample surface.  
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Microprobe ion imaging has been highly developed. In addition to pulsed lasers, 
various primary particle beams have been developed including: atomic ion beam (Cs
+
, O
-
, 
Ga
+
), small cluster ion beam (SF5
+
, C60
+
, Bi3
+
, Au3
+
), heavy cluster ion beam (Arn
+
, 
(H2O)n
+
),  massive cluster ion beam and neutral cluster beam (SO2, H2O).  The major 
current methods have already been discussed above.  
 
Figure 17. (left): microprobe ion imaging, the primary ion beam scans sample surface 
pixel by pixel; (right): microscope ion imaging, magnified ion images are projected onto 
a position sensitive detector. Reprinted with permission from Luxembourg et al. (2004), 
Copyright 2004American Chemical Society. 
 
Current commercially available microscope ion imaging mass spectrometers 
include TRIFT from Physical Electronics Inc (USA) and Cameca xf instruments from 
Cameca Inc (France).  
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TRIFT instruments have been developed by Physical Electronics Inc (USA). The 
microscope imaging capability was incorporated into a time of flight mass spectrometer. 
It can do microscope imaging for heavy m/z ions (>1000 Da, e.g. biomolecular ions).  
Heeren and colleagues have coupled MALDI and C60 primary source with TRIFT II to do 
microscope ion imaging. In Figure 18, a patterned MALDI sample (a grid on top of a 
MALDI sample) was used to test the spatial resolution of the microscope ion imaging for 
the MALDI-TRIFT. The laser spot diameter used is 200 µm. But a spatial resolution of 
~4 µm was determined from the test results.  
 
Figure 18. A fine grid was gently pressed onto a MALDI sample (insulin and substance P 
in DHB matrix). (a): 20 laser shots matrix ion image; (b): plot profile for the line scan in 
(a); (c): 80 laser shots total ion image with a higher amplification; (d): plot profile for the 
line scan in the (c). A spatial resolution of ~4 µs was determined. Reprinted with 
permission from Luxembourg et al. (2004), Copyright 2004American Chemical Society. 
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A direct comparison between microprobe and microscope ion imaging with 
MALDI-TRIFT has been performed by the Heeren group (Klerk et al. 2009). A 200 µm 
laser beam was used to raster over the sample surface for microprobe imaging. An 
improvement in spatial resolution can be observed for microscope imaging compared 
with microprobe imaging (Figure 19).  
 
Figure 19. A comparison of microscope and microprobe ion imaging with MALDI-
TRIFT on a transverse rat brain section. (Top): microscope total ion image; (Bottom): 
microprobe total ion image. A full resolution ion image for each was displayed at the 
right side. The laser diameter was ~200 µm. Microscope ion image has a higher spatial 
resolution compared with the microprobe ion image. Reprinted with permission from 
Klerk et al. (2009), Copyright 2009 Elsevier B.V. 
 
Another category of microscope ion imaging is found in Cameca xf instruments 
(e.g. Cameca 3F IMS). This instrument uses a magnetic sector mass spectrometer. Due to 
  26 
the limited mass range from the magnetic sector, this instrument is mainly used with 
elemental analysis.  
Chandra el al. have used the Cameca IMS 3F to image the distribution of boron 
inside tissue samples (Chandra et al. 2013) (Figure 20). In Boron Neutron Capture 
Therapy, the targeted localization of 
10
B into the cancer cells is important. 1-amino-3-
borono-cyclopentanecarboxylic acid (cis-ABCPC) was fed to the B16 melanoma mouse. 
A subsequent microscope ion image of 
11
B revealed uneven distribution inside the tissue 
sample. It is more concentrated inside the nucleus of some cells. 
 
Figure 20. (a): Optical image of the H&E stained B16 mouse melanoma; (b): microscope 
ion image of 
39
K revealing the cell morphology; (c): microscope ion image of 
11
B 
revealing targeted distribution inside some cells (Chandra et al. 2013). 
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Another example was to image Gd distribution after using the Gd-based magnetic 
resonance imaging contrast agents (GBMCA). This agent can be toxic, or even can result 
in death for patients due to renal failure.  It is related with a disease, Nephrogenic 
Systemic Fibrosis (NSF). Here Abraham et al. used Cameca 3F IMS to do microscope 
ion imaging of Gadolinium from NSF patient skin samples (Abraham et al. 2008) (Figure 
21).  
 
Figure 21. Microscope ion image of 
39
K, 
40
Ca, 
160
Gd, 
158
Gd and 
157
Gd in a NSF 
(Nephrogenic Systemic Fibrosis) patient skin sample. The results revealed a concentrated 
and co-localized Gadolinium with Calcium. Reprinted with permission from Abraham et 
al. (2008), Copyright 2008 Elsevier B.V. 
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1.2.6 Summary of the Current IMS Methods 
For the current imaging mass spectrometry methods, each one has its own 
advantages and disadvantages.  
Secondary ion mass spectrometry with atomic ion beam or C60 ion beam can 
achieve high spatial resolution. But they deposit a high energy density into the sample 
which results in extensive fragmentation. This is not suitable for intact biomolecular ion 
imaging. 
MALDI has a broad intact mass range. In microprobe ion imaging, the spatial 
resolution is limited by the laser size and ultimately by the matrix smearing. The 
commonly used laser diameter size is ~100 µm. The laser diameter can be smaller, but 
the expense is the acquisition time. MALDI can be coupled with a microscope ion 
imaging mass spectrometer which in principle can achieve few micrometer resolution. 
However, the matrix smear effect introduces an aberration which limits the spatial 
resolution to be ~10 µm. Also the matrix application complicates the sample processing 
and data interpretation. 
For DESI, since it is operated in atmosphere, it can only do microprobe ion 
imaging. The spatial resolution is typically limited to ~ 200 µm. Attempts have been 
made to shrink the electrospray ion beam in order to improve the resolution to ~10 µm. 
But the acquisition time will be prolonged in proportion to the square of the beam size.  
A summary of the key parameters for different imaging mass spectrometry 
techniques is presented below (Table 1). 
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Table 1. Summary of the spatial resolution, intact mass range and matrix requirement for 
different imaging mass spectrometry techniques.  
 Spatial Resolution Intact Mass Range Matrix Requirement 
SIMS with atomic 
primary ion beam 
~50 nm Mainly atomic 
secondary ions 
No 
SIMS with C60 
primary ion beam 
~250 nm ~a few hundred Da No 
MALDI ~10 µm ~10
6
 Da Yes 
DESI ~200 µm ~66 kDa No 
 
1.3 Dissertation Objective 
In Figures 4, 5 and 10, the expression of lipids was shown to be changed between 
cancer tissues and normal tissues. For early diagnostic use one would like to have lipid 
images with single cell resolution. Most eukaryotic animal cells are ~10-30 µm in size . 
SIMS with atomic primary ions or C60 can achieve sub-micron resolution but does not 
have sufficient intact mass range for lipid imaging. The spatial resolution of DESI is not 
enough for sub-cellular imaging. MALDI barely satisfies the purpose, but it requires to 
use matrix.  
The goal of this dissertation project is to develop a new IMS technique called 
Massive Cluster Impact. Compared with immunohistochemistry or current imaging mass 
spectrometry methods, the MCI method presented in this thesis can offer multiple 
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competitive advantages: (1): tag free; (2): full spectrum acquisition (survey of many 
species at one time) for biomarker discovery; (3): sub-cellular spatial resolution (~3 µm); 
(4): intact mass range covering lipids, peptides and small proteins; (5): matrix free; (6): 
high enough useful ion yield for lipids and peptides to produce useful dynamic range 
(several hundred intact biomolecular ions per 3×3 µm
2
 pixel); (7): fast measurement 
(typically seconds or minutes).  
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CHAPTER 2 
FUNDAMENTALS AND HISTORY OF MASSIVE CLUSTER IMPACT 
The massive cluster ion beam originates from electrospray technology. 
Electrohydrodynamic ionization of a liquid at a capillary surface produces charged 
droplets which can be used as primary ions to eject secondary ions for mass spectrometry 
(Mahoney et al. 1991). The extremely low energy density and large total energy 
deposited make it an ideal cluster source for desorption and ionization of intact molecules. 
This process is called as Massive Cluster Impact (MCI).  
 
2.1 Production of Massive Cluster Ions 
Electrospray technology typically includes three key elements: a capillary, 
conductive liquid and an extraction electrode. The capillary is filled with a conductive 
solution (salt is added to an organic solvent to improve its conductivity). An extraction 
electrode with a different potential from the capillary applies an electric field on the 
surface of the liquid at the capillary tip. The capillary tip surface has the strongest electric 
field due to its curvature. The liquid surface is polarized by the electric field. When the 
electric field is strong enough, it can overcome the surface tension of the liquid. The 
liquid surface breaks down and emits charged droplets. The charged droplets are 
accelerated by the electric field to a velocity of several km/s and impact the sample. The 
charged droplet emission process can be summarized as liquid accumulation at the 
capillary surface, Taylor cone formation due to the electric field and ejection of a charged 
droplet jet (Marginean et al. 2004). Large, highly-charged droplets can be produced and 
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accelerated by the electric field. This droplet beam is called a massive cluster ion beam 
since the cluster size is much bigger than other cluster ion beams being used (e.g. C60, 
argon cluster). Glycerol is used in the present work for an electrospray solvent since it 
has a low vapor pressure which is compatible with vacuum operation. Its surface tension 
(64 mN/m at 20 
o
C) is high compared with other common organic solvents (formamide, 
ethylene glycol). Ammonium acetate was dissolved into the glycerol to increase its 
conductivity. A voltage of -10 kV is applied to the solution in the capillary. Together 
with the ground potential at the extraction electrode, the electrospray process can be 
initiated.  
There are also groups around the world doing electrospray impact using water or 
ionic liquids. Hiraoka and colleagues electrospray water in the atmosphere (Ninomiya et 
al. 2013; Hiraoka et al. 2006; Asakawa and Hiraoka 2011; Asakawa et al. 2007). The 
water droplets are introduced into vacuum through a nozzle. A quadrupole ion guide is 
used to select the specific water cluster ions to go to the sample. Intact desorption and 
ionization was demonstrated for small protein samples(Hiraoka, Mori, and Asakawa 
2006). Fujiwara and colleagues have developed an ionic liquid electrospray in 
vacuum(Fujiwara et al. 2011, 2010). 
 
2.2 Characteristics of Massive Cluster Ions 
Stimpson et al showed plots of the cluster ion current decay when a continuous 
glycerol (with NaI) massive cluster ion beam was abruptly switched off(Stimpson and 
Evans 1978) (Figure 22).  
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Figure 22. Decay of the cluster ion beam current when a continuous beam was stopped 
for field free time of flight mass/charge analysis. Higher flight time corresponds to higher 
mass to charge ratio. The initial signal drop corresponded to the glycerol molecular ion 
emission. Decay patterns changed from 25 
o
C to -30 
o
C. Reprinted with permission from 
Stimpson et al. (1978), Copyright 1978 Elsevier B.V.   
 
The plot of the cluster ion beam current decay at 25 
o
C was differentiated to 
generate another plot below (Figure 23) showing the composition of this glycerol massive 
cluster ion beam.  
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Figure 23: Glycerol cluster ions m/z distribution calculated from Stimpson and Evans 
(Stimpson and Evans 1978). Initial high intensity component for m/z ~100 corresponded 
to glycerol molecular ions. Highest cluster ion beam component was found at ~m/z 
33,000. 
 
In Figure 23, the initial high intensity ions correspond to glycerol molecular ions. 
These had ~100 eV/nucleon and a velocity of 150 km/s.  
The most abundant heavy cluster ions were located at m/z ~33,000. Based on the 
Rayleigh limit at which an equilibrium is achieved between the surface tension and the 
charge repulsion at the droplet surface, the size and charge number can be calculated for 
this cluster ion (http://phd.marginean.net/rayleigh.html, surface tension: 0.064 N/m, 
molecular mass 92 au, density: 1261 kg/m
3
). It had 5×10
4
 glycerol molecules, a mass of 
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~5 MDa, carried ~140 charges, ~0.3 eV/nucleon energy density, 11 nm radius and 
impacted the target with a velocity of ~8 km/s.  
There was a long tail of heavy cluster ions located above m/z 80,000. Cluster ions 
with m/z 80,000 had a radius of ~20 nm, 5 km/s velocity and carried ~350 charges with 
0.1 eV/nucleon. The intensity of cluster ions over m/z 80,000was relatively small 
compared with m/z at 33,000. 
Cluster ions with different energy density and velocity will have different effects 
on fragmentation. With the same acceleration voltage, lower m/z ions have higher energy 
density and can create more surface and in-depth fragmentation in the sample. The light 
component of the beam in Figure 7 constituted 10% of the beam current. It should be 
noted that this light component is mainly single charged glycerol molecular ions. The 
most probable cluster ions carried ~100 charges. This means that ~90% of the total 
particle flux is low m/z ions. This m/z region is not good for intact sputtering and 
ionization of molecular ions. 
             As the temperature was reduced, Stimpson et al. showed that the percentage of 
low m/z ions increased. At -30 
o
C, majority of the ions were the low m/z ions. The way 
temperature affected the cluster ion beam distribution was through increasing viscosity, 
which reduced the flow rate. When the flow rate was extremely low, the electrospray 
process generated mostly molecular ion emission. In the present application of soft 
sputtering and ionization, the heavier cluster ions are preferred, thus higher temperature 
and faster flow rate are preferable.  
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             The highest intensity of massive cluster ions in Figure 7 locates ~ m/z 33,000. A 
comparison of the energy density between the m/z 33000 glycerol massive cluster ion, 
the oxygen primary atomic ion bean and C60 ion beam is given below in Table 2. 
Table 2. Comparison of energy density among oxygen ion beam, C60 ion beam and 
glycerol ion with m/z 33000 accelerated under the same voltage of -10 kV. 
Primary Ion Species O
-
 C60 Glycerol (m/z 33000) Cluster 
Energy density (eV/nucleon) ~600 ~10 ~0.3 
 
The energy density in a glycerol cluster ion (m/z 33,000) is 2000 times smaller 
compared with the oxygen atomic ion beam. The extremely low energy density facilitates 
the intact sputtering of ionized sample molecules. 
Another advantage of the massive cluster ions produced by the electrospray 
process is the huge number of charges carried by one droplet. The m/z 33,000 glycerol 
cluster ion carries ~140 charges. Under the same electric field, it carries a total energy 
(~1.4 MeV for 10 kV acceleration) 140 times bigger than a single charged primary ion. 
The bigger total energy deposited improves the sputter yield and produces shock wave 
heating at the sample. 
             It should be noted that the glycerol cluster ion distribution in our system might be 
different than Simpson's since a different diameter capillary (100 µm instead of 200 µm) 
and different solute (ammonium acetate instead of NaI) were used. But the general 
phenomenon should be similar: a light ion component composed of singly-charged 
glycerol molecule and a broad distribution of massive cluster ions. 
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2.3 Impact of Massive Cluster Ions 
When the impact velocity of glycerol cluster ions is greater than the sound 
velocity in the matrix, the deposited energy cannot dissipate fast enough. The volume of 
the cluster ions and a similar volume of the sample material are compressed giving rise to 
shock heating. A temperature of ~ 1000 K and a pressure of ~30 GPa can be achieved in 
the shock wave heating for 6 km/s impact velocity(Mahoney et al. 1992). The immediate 
heating of the sample materials results in a micro-explosion that ejects ionized sample 
molecules out of the sample surface. The explosion process results in an expanding 
plume that may have a cooling effect preventing sample molecules from fragmentation.  
Dr. Leonid Zhigilei at University of Virginia did a simulation of a water cluster 
ion impacting a rigid target (Zhigilei 2001). A water droplet with 3×10
5
 water molecules 
impacted the target at 2 km/s. Snapshots from the simulation process are shown below in 
Figure 24. The water droplet exploded after the impact.  
 
 Figure 24: Snapshots from MD simulations of water cluster impact. Impact velocity was 
2 km/s. The red color represents water molecules at higher temperature due to shock 
heating. After the impact, all the water molecules were vaporized. 
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When the sample is not a rigid target, not only the cluster ion is compressed and 
explodes, a similar volume to the cluster ion of the sample materials underneath also 
undergoes the compression and explosion process. A cartoon picture is shown below 
(Figure 25) about this process.  
 
Figure 25. Cartoon images of a glycerol cluster ion impacting on a soft sample. The blue 
color represents the glycerol cluster ion. The green color represents the sample molecules. 
The red color represents the molecules at high temperature in the shock wave heating 
process. The glycerol droplet together with a similar volume of sample material is 
sputtered into the gas phase. 
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2.4 History of Massive Cluster Impact 
The idea of MCI was first brought forward by Dr. Williams and John Mahoney in 
a 1983 NSF proposal. Intact desorption and ionization was first demonstrated by 
Mahoney et al. (1991) from a sample dissolved in glycerol. Fabris et al. (1995) showed 
intact multiple charged peaks of bovine carbonic anhydrase II (29kDa) in thioglycerol 
solution.  The first matrix-free detection of insulin and cytochrome c was reported by 
Cornett et al. (1994) (Figure 26). The ability of MCI to generate intact biomolecular ions 
from neat samples suggested that MCI might be a useful alternative to MALDI for 
imaging at length scales smaller than the MALDI matrix limit of ~10-20 µm and so 
inspired the work described in this thesis.  
 
Figure 26: Single charged and multiple charged insulin peaks (left) and cytochrome c 
peaks (right) without matrix was first reported by Cornett et al.(Cornett, Lee, and 
Mahoney 1994) with glycerol cluster ions impact. Reprinted with permission from 
Cornett et al. (1994), Copyright 1994 John Wiley & Sons, Ltd. 
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CHAPTER 3 
INSTRUMENTATION OF MCI-TRIFT 
Massive cluster impact produced from the electrospray process gives us a new 
way of sputtering and ionizing sample molecules with extremely low energy density. The 
question remaining is what kind of mass spectrometer to use and how to do imaging. The 
massive cluster ion beam is a diverging beam due to the curved electric field at the 
capillary surface. It also has a broad m/z distribution and therefore a broad velocity 
distribution. These two problems make the beam difficult to focus or pulse. So 
microprobe ion imaging with a pulsed beam is not a feasible approach here. The option 
left is microscope ion imaging. In the work described here, an ion microscope imaging 
mass spectrometer, Triple Focusing Time of Flight Mass Spectrometer (TRIFT-I) from 
Physical Electronics Inc, is used. Because the cluster beam could not be pulsed with good 
time resolution, the secondary ion beam was pulsed for time-of-flight operation. 
 
3.1 MCI Source Setup 
As discussed in Chapter 2, in order to start the electrospray process, a conductive 
liquid, a capillary and an electric field strong enough to start the electrospray are needed. 
The MCI source was built on a Delrin flange (Figure 27) installed on the TRIFT mass 
spectrometer at an angle of 45
o 
with respect to the sample surface. This position 
originally was designed for a Cesium ion source. A Delrin flange was used to insulate the 
capillary from ground. When the source is not running, the glycerol solution can flow 
along the capillary to the flange possibly making a short circuit if the flange was made of 
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metal. A Delrin reservoir was filled with a conductive liquid which is the 1.5 M 
ammonium acetate in glycerol solution. The schematic of the Delrin reservoir design is 
attached in Appendix A (Figure A.1.). A voltage of -10 kV was fed into the solution in 
the reservoir. A vacuum/pressure pump (Thermo Scientific, Model No.420-1901) was 
used to adjust the flow rate. Normally atmospheric pressure was sufficient to drive the 
glycerol flow; occasionally it might be necessary to pressurize the reservoir for several 
seconds to start the flow. A 22 cm length of PEEK tubing (part number 1546, Upchurch 
Scientific, USA) was used to conduct liquid from the reservoir to a valve. The valve (part 
number P-732, Upchurch Scientific, USA) was used to manually turn on or turn off the 
solution flow in the capillary. The voltage of the source must be turned off before 
operating the valve. The other side of the valve was connected with a fused silica 
capillary (100 µm ID and 360 µm OD) (part number 1932, Upchurch Scientific, USA). 
The length of this fused silica capillary was 6 cm. The capillary length inside the vacuum 
was 8 mm. The capillary was cut using a carbide tubing cutter. The surface was polished 
with sand paper (1000 grit) (Figure 27c). The capillary was inserted through a tiny hole 
on to the Delrin flange. The connection of the capillary to the flange was done by using 
an Adapt Assy F-200 × ¼-28 male (part number: P-640, Upchurch Scientific, USA). The 
sealing of the connector to the flange was done by screwing the connector tightly on the 
Delrin flange (press the end tightly onto the surface of the Delrin). The flange schematic 
is in Appendix A (Figure A.2.). An extraction electrode (4 mm thickness, 22 mm OD, 6 
mm ID) at ground potential was placed 20 mm away from the capillary surface. The 
schematic of the extraction electrode is in Appendix A (Figure A.3.). Optical images of 
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the MCI setup are shown in Figure 28. The reservoir, the pump, the tubing and the valve 
were sheltered by a plastic box (LEXAN Sheet, poly, clear) and a Delrin substrate. 
 
Figure 27. a): MCI source design: the voltage of -10 kV was applied to the solution in the 
reservoir, a vacuum/pressure pump was used to adjust the flow rate, a valve was used to 
turn on/off the source, the distance of capillary inside the vacuum was 8 mm. b): Images 
for the assembly of the MCI source setup. c): Optical images for the front view (left) and 
side view (right) of fused silica capillary used in the MCI source. The capillary had a 100 
µm ID and 360 µm OD.  
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Figure 28. Images of the MCI source setup. The Delrin reservoir was filled with 1.5 M 
ammonium acetate in glycerol solution. A valve was used to turn on and turn off the 
solution flow inside the capillary. 
 
The voltage difference between the capillary and the extraction electrode 
generates an electric field to start the electrospray process. The emitted charged glycerol 
droplets were accelerated by the electric field through the aperture of the extraction 
electrode. The charged droplets flew through a 3 mm×1 mm entrance slit to the sample. 
The sample was held at +3055 V. The potential difference between the capillary and the 
sample was 13 kV. A SIMION simulation is shown here (Figure 29) for the MCI source.  
 
Figure 29: SIMION (an ion optics simulation program) simulation of electrospray 
process. The charged droplets are accelerated and fly through the aperture of extraction 
electrode and the entrance aperture to the sample. 
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The curved electric field at the capillary surface makes a diverging cluster ion 
beam. Together with the broad distribution of m/z ions, it is difficult to pulse or focus this 
primary cluster ion beam. Here we use an ion microscope imaging mass spectrometer 
called TRIFT to solve this problem.  
 
3.2 MCI-TRIFT Instrumentation 
The Triple Focusing Time of Flight mass spectrometer (TRIFT-I) was invented 
by Bruno W. Schueler in the early 1990s (Schueler 1990; Schueler 1992). It is a time of 
flight ion microscope imaging mass spectrometer. The bombardment by the primary ion 
beam ejects secondary ions out of the sample surface that are extracted and accelerated 
by the extraction electric field (3055 V) into a field-free region. Different m/z ions have 
different velocities, thus different flight times arriving at the detector. The m/z can be 
calculated through the flight time. Stigmatic ion optics ensured that ions leaving the 
sample surface stored their relative position information in the transmission process and 
were projected onto an image at a position sensitive detector (dual microchannel plates). 
Two Einzel lenses (lenses I and II) in the secondary column together with the stigmatic 
imaging properties of the three ESAs (spherical electrostatic sectors), produced a 60× 
magnified image of a sample area about ~350 μm in diameter at the dual microchannel 
plates and a phosphor screen.   
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Figure 30. The MCI source was installed on to the TRIFT instrument and fixed on a 
Delrin plate. The whole source was protected inside a plastic box.  
 
The reservoir in the MCI source was under atmospheric pressure.  Negative 
potential on the capillary helped avoiding arcing between the capillary and the extraction 
electrode. Electron bombardment with a positively charged capillary was found to 
degrade the capillary tip within several hours of operation. Also the negative potential 
together with the positive potential at the sample gave increased impact energy.  It was 
discovered by Williams and Aksyonov (Aksyonov and Williams 2001) and later 
confirmed by Hiraoka et al. (Asakawa and Hiraoka 2011) that the polarity of the 
impacting massive cluster ions does not influence ion formation efficiency.  
Because it is difficult to pulse the heterogeneous cluster ion beam, the primary ion 
beam was run continuously and the secondary ion beam was pulsed for time-of-flight 
mass analysis (Figure 31). For this, blanker plates were used. Two parallel metal plates, 
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with one plate at ground potential and the other plate at 200 V, can deflect the secondary 
ion beam off the central axis. The voltage on the blanker plate can be turned on and off 
with a pulse generator and a blanker box. The continuous secondary ion beam extracted 
from the bombarded sample surface was chopped by dropping the voltage across the 
blanker plates (blanker I), normally held at 200 V, to zero.  The pulse width, and hence 
mass resolution, is adjustable, with a minimum nominal pulse width of 200 ns, but must 
be chosen to be larger than the transmission time of the secondary ions of interest through 
the blanker I region (length ~5 cm) (Zhang, Franzreb, and Williams 2014).  Effective 
pulse width is the applied pulse width minus the ion transmission time and so varies for 
different m/z values in a mass spectrum. Typical pulse widths applied at blanker I ranged 
from several μs to tens of μs. The resulting secondary ion pulse traveled through a series 
of three spherical electrostatic sectors (ESA) which functioned as stigmatic imaging 
lenses while also providing time-focusing for ions of different initial energies. The time 
focus plane was exactly coincident with the image focal plane at the first microchannel 
plate of the detector array. 
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Mass selection of the secondary ion species to be imaged was made using a 
second pulse at deflector plates at the exit of the electrostatic sectors (blanker II) with an 
appropriate time delay. Blanker II was usually operated with the same deflection voltage 
of 200 V and the same pulse width as for blanker I, except for useful ion yield 
measurements, for which the pulse width for blanker II was chosen to be longer than for 
blanker I to allow evaluation and subtraction of the ion background underneath the peak 
of the imaged ion species.   
In order to improve detection sensitivity for heavy species, the detector was 
operated with a post-acceleration voltage of -9 kV which reduced the magnification 
somewhat.  The ion image on the phosphor was recorded by a DSLR camera (Canon 
EOS) with a 60 mm macro lens (Figure 32).  Imaging times were typically a few minutes.   
 
Figure 32. A Canon EOScamera with 60 mm macro lens was installed to look at the back 
of the phosphor screen. Bulb imaging mode with manually determined exposure time. 
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Lens I was close to the sample where vacuum quality is poor and for low 
aberrations was operated as an acceleration-deceleration Einzel lens at a rather high 
negative voltage (~ -8 kV for positive secondary ions).  The poor vacuum during glycerol 
spraying led to some overloading of the instrument power supply for this lens. A 
Spellman power supply which can drive high current was used to stabilize the -8kV at 
Lens I. An effort to achieve microscope-mode ion imaging with lens I instead in 
deceleration-acceleration mode at a smaller positive voltage was not successful.  
A small aperture or contrast diaphragm (CD) was located at a crossover of the 
secondary ion trajectories in front of the first electrostatic analyzer (ESA1) and was used 
to limit the angular divergence of ions entering the ESA flight section and so to limit 
spherical aberration in the ion image. Five different aperture sizes were available on a 
moveable aperture strip. Smaller apertures improve the image resolution, but at the 
expense of lower ion transmission.  Useful ion yield measurements have been made using 
the 0.2 mm diameter CD that has been demonstrated to give ~ 3 µm image resolution; in 
addition measurements have been made using the biggest CD, 2 mm in diameter.  The 
latter measurements reflect UY values that could be achieved if it were possible to focus 
the massive cluster beam for rastered beam imaging so that the mass spectrometer could 
be operated at maximum transmission.   
For detection of negative secondary ions (sample voltage -3055 V), the MCI 
emitter voltage was increased to -14 kV.  The post acceleration voltage was +6 kV to 
avoid arcing at the positively biased phosphor screen.   
  50 
The duty cycle of the time-of-flight measurement is defined as the ratio of the 
effective pulse width at blanker I (i.e. corrected for the transmission time of the selected 
ion species through the 5 cm long blanker I) to the chosen maximum flight time (i.e. 
inverse Blanker I pulse repetition rate). The duty cycle is mass-dependent because 
transmission times through Blanker I differ with mass, and scales inversely with the mass 
resolution of the ion species of interest; a typical value of the duty cycle used in these 
measurements ranged from 0.5% to 4 %. For continuous sputtering, the sampling 
efficiency is the same as the duty cycle – this is the fraction of the sputtered material that 
is available for sampling in the experiment.  
 
3.3 Modifications of TRIFT 
              The major purpose of the modifications was to improve the vacuum inside the 
mass spectrometer. The MCI source electrosprays glycerol solution into vacuum. It 
makes the vacuum of the TRIFT poor that it cannot have a stable operation (arcing 
between the capillary and the extraction electrode, arcing at Lens 1 and high background 
noise at the detector). Other modifications have been done to provide stronger power 
supply for stable voltage during measurement, selected ion imaging and detection for 
heavy secondary ions.  
              Details of the modifications are summarized:  
(1) A liquid nitrogen cold finger was added through a window to the sample chamber. It 
was close to the MCI source. It can improve the vacuum by ~10 times from 10
-5
 torr to 
10
-6
 torr range. 
  51 
(2) Additional plastic insulation was added to the Lens 1 -8 kV feed-through cable. This 
reduced the arcing for the feed-through cable to ground. 
(3) A Spellman power supply (0-10 kV, 0-20 mA) was used to replace the original 
instrument power supply to stabilize the -8 kV lens voltage. Small fluctuations of Lens 1 
voltage can degrade the image resolution. 
(4) Slits were cut into the flight tube near lens I for more efficient differential pumping 
with the 230 L/s turbo molecular pump attached to the sample chamber. 
(5) A small aperture (7 mm in diameter) was inserted before lens II to improve 
differential pumping in the flight chamber and detector region. 
(6) Post acceleration was installed on the front microchannel plate to improve the 
detection efficiency for the heavy secondary ions. The typical post acceleration voltage 
used was 9 kV.  
(7) A Canon EOS camera with 60 mm macro lens was used in "Bulb" mode to record ion 
images with a manually controlled exposure time.   
            With these modifications, stable operations at a pressure ~ 5 x 10
-6
 torr in the 
sample chamber were achieved with the massive cluster ion source in operation.  
 
3.4 Timing Scheme 
             Because it is difficult to pulse the primary cluster ion beam with good time 
resolution, the secondary ion beam has to be pulsed for time of flight mass analysis. A 
flow chart of the timing scheme for the time of flight mass analyzer and ion selection for 
imaging is shown in Figure 33.  
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Figure 33. A flow chart showing the signal input and output for secondary ions pulsing 
for the time of flight mass analysis and selection for imaging. A computer, control unit, 
pulse generator and blanker box were used to supply a pulsed voltage of 200 V to the 
blanker I and blanker II. The signal output from the phosphor screen comes back to the 
computer to produce a spectrum.  
 
The timing system was composed of several elements: a computer, a control unit, 
a pulse generator (Stanford Research Systems Inc.), a blanker box and the detector. The 
computer together with the control unit sent a triggering signal to the pulse generator. 
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The pulse generator can generate two independent pulses with adjustable delay and 
interval. These two pulses controlled the blanker box to generate two square wave pulses 
of 200 V to 0 V with selected time windows. The first voltage pulse went to Blanker I to 
produce the secondary ion pulse. The second voltage pulse went to Blanker II to select 
the ion window going to the detector with an appropriate delay from Blanker I. When the 
ions impacted on the detector, a current output from the phosphor screen went back to the 
control unit and the computer. The detector was operated in a multi-stop mode, i.e. a 
single ion pulse at the detector produced a one-bit signal in the computer at the 
corresponding time point. The dead time for one stop is ~100 ps which is enough for our 
application. With the flight time recorded by the computer, a mass spectrum can be 
produced. The mass spectrum was calibrated using a high resolution mass spectrum (a 
small blanker I pulse width was used, e.g. 500 ns) (H
+
, Na
+
, K
+
 peaks were used). The 
Canon EOS camera was manually determined for exposure time. The ion image from the 
back of the phosphor screen was recorded.  
 
3.5 Mass Resolving Power (MRP) 
Mass resolving power is an important parameter for a mass spectrometer. In a 
typical time of flight mass analyzer mass spectrometer, the MRP is determined by the 
total flight time and the effective pulse width of a given m/z ion (Figure 34).  
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The flight time for a given m/z ion to fly through a distance can be calculated with 
Equation 1. It is dependent on the acceleration electric field (V) and the distance (L). The 
effective pulse width (Δt2) is equal to the blanker I pulse width (Δt1) minus the 
transmission time (ttrans) for a specific m/z ion to fly through the blanker I. Mass 
resolving power is equal to the mass divided by the FWHM (full width at half maximum). 
It is also equal to the total flight time (T) divided by 2 times the effective pulse width 
(Δt2). 
Transmission time through Blanker I 
                   
   
 
                      (1) 
V:       sample potential (+3055 V).  
L:        length for blanker I (5 cm).  
Effective pulse width Δt2 
                                                  (2)   
Δt2:      effective pulse width 
Δt1:      blanker I pulse width 
ttrans:   flight time through blanker I 
Mass resolving power (MRP) 
    
 
  
 
 
    
                                        (3) 
T:         total flight time 
In reality, the experimental effective pulse width was found to be larger than the 
theoretical value. Ions near the end of Blanker I when Blanker I was turned to 200 V 
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could still go through the secondary column and impact the detector. Details will be 
discussed below in reference to the sphingomyelin spectra in Figs. 35-38. 
Several conclusions can be obtained from the above equations: 1) Mass resolution 
of a given m/z is dependent on a): total flight time; b): blanker I pulse width; c): 
transmission time; 2) With the same blanker I pulse width, smaller m/z ions have shorter 
transmission time, longer effective pulse width, higher integrated intensity, broader peak 
width, lower mass resolution; 3) A given m/z ion cannot pass through blanker I when its 
transmission time is longer than the blanker I pulse width; 4) With the same m/z ion, a 
longer blanker I pulse width lets more ions go through resulting in more ion counts but 
lower mass resolution. There is a conflict between the mass resolution and the duty cycle 
of the sample molecular ions (defined as the number of molecular ions detected divided 
by the number of ions generated at the sample surface). 
Mass resolving power for this mass spectrometer can be almost infinitely 
increased, but the transmission of the secondary ions is decreased correspondingly. When 
the duty cycle drops below a certain range, a useful mass spectrum or ion image cannot 
be obtained.   
An example to show the relationship between the mass resolution and blanker I 
pulse width is shown here for sphingomyelin (m/z: 731). The sphingomyelin molecular 
ion (m/z 731) has a transmission time of 1.8µs through blanker I and a total flight time of 
~60 µs to the detector. 5mg of sphingomyelin powder was dissolved in 50% 
formamide/methanol to make a solution of 2×10
-3
 mol/L. A few nL of this solution was 
deposited on a silicon wafer and vacuum dried.  
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With blanker I pulse width at 4.0 µs, a spectrum of sphingomyelin is shown in 
Figure 35. The sphingomyelin monomer, dimer, trimer and tetramer peaks, all singly 
charged, were observed. The mass resolution of the singly charged peak was ~13. This 
spectrum also demonstrates that how soft the massive cluster ion beam was since the 
tetramer single charged peak was observed. The massive cluster impact broke neither the 
chemical bonds inside the molecules, nor the intermolecular forces.  
 
Figure 35. Full mass spectrum (a) and partial mass spectrum (b) of sphingomyelin (m/z 
731) with blanker I pulse width at 4.0 µs. Sphingomyelin single charged, dimer single 
charged, trimer single charged and tetramer single charged peaks were observed. The 
mass resolution of the monomer peak was ~13. The effective pulse width and the 
transmission time through Blanker I for the monomer peak were2.3 µs and 1.6 µs. 
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With blanker I pulse width at 3.0 µs, a spectrum of sphingomyelin is shown in 
Figure 36. The tetramer singly charged peak has disappeared compared with Figure 21 
because its transmission time (~3.5 µs) was longer than the blanker I pulse width.  The 
mass resolution of the single charged peak was increased to ~22.  
 
Figure 36.Full mass spectrum (a) and partial mass spectrum (b) of sphingomyelin (m/z 
731) with blanker I pulse width at 3.0 µs. The sphingomyelin tetramer peak disappeared 
compared with Figure 35. The mass resolution of the monomer peak was increased to 
~22 compared with 4 µs blanker I pulse width. The effective pulse width and the 
transmission time through Blanker I for the monomer peak were 1.4 µs and 1.6 µs. 
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With blanker I pulse width at 2.5 s, a spectrum of sphingomyelin is shown in 
Figure 37. Now the trimer singly charged peak has also disappeared because its 
transmission time (3.0 µs) was longer than the blanker I pulse width.  The mass 
resolution of the single charged peak was increased to ~32. Note that the dimer signal is 
still seen even though the calculated transmission time is 2.5 µs. 
 
 Figure 37.Full mass spectrum (a) and partial mass spectrum (b) of sphingomyelin (m/z 
731) with blanker I pulse width at 2.5 µs. The sphingomyelin trimer peak disappeared 
compared with Figure 36. The mass resolution of the monomer peak was increased to 
~32 compared to 3 µs blanker I pulse width. The effective pulse width and the 
transmission time through Blanker I for the monomer peak were 0.9 µs and 1.6 µs. 
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With blanker I pulse width at 2.0 s, a spectrum of sphingomyelin is shown in 
Figure 38. Now the dimer singly charged peak is not seen because its transmission time 
(2.5 µs) was longer than the blanker I pulse width.  The mass resolution of the single 
charged peak was increased to ~78.  
 
Figure 38. Full mass spectrum (a) and partial mass spectrum (b) of sphingomyelin (m/z 
731) with blanker I pulse width at 2.0 µs. The sphingomyelin dimer peak disappeared 
compared with Figure 37. The mass resolution of the monomer peak was increased to 
~78 compared with 2.5 µs blanker I pulse width. The effective pulse width and the 
transmission time through Blanker I for the monomer peak were 0.4 µs and 1.6 µs. 
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From the above sphingomyelin spectrum changes from 4.0 µs to 2.0 µs blanker I 
pulse width, the mass resolution was improved from 13 to 78, but the duty cycle of the 
secondary ions was decreased. When the blanker I pulse width was smaller than the 
transmission time for a given species through blanker I, the corresponding peak 
disappeared. A balance needs to be kept between the mass resolution and the peak 
intensity. 
The experimental transmission time is smaller than the theoretical transmission 
time. Here the monomer transmission time was calculated based on equation 2 and 3. 
First the mass resolving power was calculated based on the mass and the FWHM. The 
total flight time was known. So the experimental effective pulse width could be 
calculated. The transmission time is equal to the blanker I pulse width subtracted by the 
effective pulse width. The experimental transmission time for sphingomyelin monomer 
was calculated from the above spectra to be ~1.6 µs. It is smaller than the theoretical 
transmission time 1.8 µs. This is because of ions near the end of Blanker I when the 200 
V was turned on were only deflected partially that they could still arrive at the detector.  
When the mass resolution was improved from 4 µs blanker I pulse width to 2.0 µs, 
the relative intensity of low m/z ions to the monomer peaks were decreased and the signal 
to background ratio of the monomer was improved. This implied to us that a high mass 
resolution was preferable to minimize signal/background. But in this TRIFT instrument, 
the mass resolution scales inversely with the duty cycle. In order to solve this problem, 
either the primary ion beam needs to be pulsed or a DC secondary ion microscope 
imaging mass spectrometer is required. 
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CHAPTER 4 
MASS SPECTRA OF ORGANICS, LIPIDS, PEPTIDES AND PROTEINS 
Intact desorption and ionization of biomolecules is important for imaging mass 
spectrometry to be useful in discovering the distribution of intact biomolecules. Here 
mass spectra of various organic molecules, lipids, peptides, proteins and oligonucleotides 
were obtained to demonstrate the intact mass range for MCI technology. Mass spectra 
were typically obtained using the third contrast diaphragm (CD3, 0.21 mm diameter) 
which is the same for imaging test at next chapter.  
Mass spectra of the compounds discussed below which have been obtained before 
with other mass spectrometry methods (SIMS, MALDI, EDI and so on) are cited and 
reprinted (with permission) here for comparison. EDI (Electrospray Droplet Impact) is 
developed by Kenzo Hiraoka and his colleagues. It uses water cluster impact to desorb 
and ionize molecules. MCI has been demonstrated to have similar performance for 
molecular peak detection compared with MALDI, EDI, or better performance than the 
SIMS with small cluster ion beam.  
 
4.1 Organic Molecules 
α-NPD (N,N'-Di(1-naphthyl)-N,N'-diphenylbenzidine) (588 Da) was donated by 
Dr. Jiro Matsuo (Kyoto University). It was deposited as a homogeneous layer on silicon 
wafer with a thickness of 112.9 nm.  α-NPD is a material used in OLED devices. 
Molecular peak of α-NPD was obtained before using Laser Desorption/Ionization TOF 
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(LDI-TOF) by Takaya Satoh (MS Business Unit, JEOL Ltd.). Here MCI-TRIFT was 
used to get a similar molecular peak with 1.4 µs blanker I pulse (Figure 39).  
 
Figure 39. (a): structure of α-NPD, this is a material used in OLED devices; (b) spectrum 
of α-NPD, 1.4 µs blanker I pulse width, the 1+ peak was clearly observed. 
 
2-TNATA (4,4',4''-Tris[2-naphthyl(phenyl)amino]triphenylamine)  (896 Da) was 
also donated by Dr. Jiro Matsuo. A thickness of 106 nm of 2-TNATA was deposited on 
silicon wafer. 2-TNATA is a material used in OLED devices. The blanker I pulse width 
was 2.0 µs. The 1+ peak was clearly observed (Figure 40).  
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Figure 40. (a): structure of 2-TNATA. This is a material used in OLED devices; (b): mass 
spectrum of 2-TNATA, 2.0 µs blanker I pulse width, the 1+ peak was clearly observed.  
 
Irganox 1010 (1178 Da): this detergent multilayer sample was donated by Ian 
Gilmore (National Physical Laboratory, UK) and used without further processing. It 
contained three 95 nm and two 47.5 nm thick layers of irganox 1010 interspersed with 
2.5 nm layers of irganox 314. Structure of irganox 1010 was shown in Figure 41a. A 
negative ion spectrum of irganox 1010 was obtained before by Lee et al. (Lee et al. 2010) 
using Ar700
+
 (no characteristic peaks were shown in positive spectrum) (Figure 41b). The 
molecular peak was not observed in this spectrum. Fragment peaks were used to monitor 
the irganox 1010 parent molecules.  
However, in the spectrum obtained with MCI, an intense molecular peak was 
observed (Figure 41c). Blanker I pulse width was 2.2 µs.  
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Figure 41.(a): structure of Irganox 1010, it is an additive into polyolefin; (b): negative ion 
spectrum of irganox 1010 obtained using Ar700
+
, molecular peak was not observed, 
fragment peaks were used to monitor the irganox 1010 parent molecule, reprinted with 
permission from Lee et al. (2010), Copyright 2010 American Chemical Society;  (c): 
mass spectrum of Irganox 1010 obtained with MCI-TRIFT, 2.2 µs blanker I pulse width. 
The 1+ peak was clearly observed. The four fragment peaks in a series were due to the 
loss of a single side chain, R, then subsequent additional losses of t-butyl groups from the 
remaining side chains.   
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Rhodamine B chloride (mass without Cl
-
, 443 Da): the structure of this molecule 
is shown in Figure 42a. Figure 42b shows a spectrum of rhodamine B obtained by EDI 
(Hiraoka, Asakawa, and Takaishi 2013). The molecular peak without Cl
-
 was observed.  
The sample in the MCI-TRIFT test was purchased from Sigma Aldrich (St. Louis, 
MO) and dissolved in deionized water to make a 1.0×10
-4
 mol/L solution. The solution 
was deposited on a silicon wafer and air dried. Blanker I pulse width was 2 µs. The single 
charged peak (Figure 42c) represented the rhodamine B without the Cl
-
 ion.   
 
Figure 42.(a): structure of rhodamine B molecules, it is a fluorescent dye and a 
diethylammonium chloride;(b): mass spectrum of rhodamine B acquired by EDI, the 
molecular peak was observed, reprinted from Hiraoka, Asakawa, and Takaishi (2013), 
Copyright 2013 John Wiley & Sons, Ltd.; (c): mass spectrum of rhodamine B obtained 
by MCI-TRIFT, the 1+ peak without the Cl
-
 ion was clearly observed. 2 µs blanker I 
pulse width.  
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4.2 Lipids 
The phosphocholine has two side chains (R, R') (Figure 43a). Figure 43b shows a 
mass spectrum obtained by EDI for 1-palmitoyl-2-stearoyl-sn-glycero-3-phosphocholine 
(PC16:0/18:0) (Asakawa et al. 2010). The (M+H)
+
 and (M+Na)
+
 peaks were observed. 
Two fragment peaks at m/z 479 and m/z 507 corresponded to the loss of palmitoyl or 
stearoyl (283Da) side chain.   
In the MCI-TRIFT test, L-α-phosphatidylcholine (from egg yolk, a major 
component in eukaryotic cell membrane) was purchased from Sigma Aldrich (St. Louis, 
MO) and dissolved in formamide to make a 1.8×10
-4
 mol/L solution. The solution was 
deposited on a silicon wafer and air dried. This was a natural sample and contained a mix 
of different side chains (e.g. 33% palmitic, 31% oleic, 13% stearic, 15% linoleic and 
other minor fatty acids). A fairly high resolution mass spectrum was obtained using 2 µs 
blanker I pulse width (Figure 43c). Peak A was identified as the phosphocholine carrying 
a palmityl (C16) and oleyl (C18) (281Da) side chains. Peak B could be an overlap of two 
oleyl side chains or (A+Na)
+
. Peak C and D corresponded to loss of the palmityl or oleyl 
side chain of peak A. Loss of an oleyl side chain of peak B might also contribute to peak 
C. The identity of the peak at m/z 850 is unknown. The L-α-phosphatidylcholine 
monomer, dimer and trimer, all singly charged peaks, were observed using a blanker I 
pulse width of 6 µs, the mixture led to somewhat broadened (unresolved) peaks (Figure 
43d).   
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Figure 43.(a): structure of phosphocholine with R and R' side chains; (b): mass spectrum 
of 1-palmitoyl-2-stearoyl-sn-glycero-3-phosphocholine (PC16:0/18:0) obtained by EDI, 
[M+H]
+
, [M+Na]
+
 and two fragments peaks (m/z 479 and 507, loss of palmitoyl or 
stearoyl correspondingly) were observed, reprinted with permission from Asakawa et al. 
(2010), Copyright 2010 John Wiley & Sons, Ltd.; (c): the mass spectrum of egg yolk L-
α-phosphatidylcholine with 2 µs blanker I pulse width, peak A had a C16 and C18 side 
chains, peak B was attributed to two C18 side chains or [A+Na]
+
, peak C and D 
corresponded to loss of a single C16 or C18 side chain from peak A; (d): the mass 
spectrum of egg yolk L-α-phosphatidylcholine with 1+, dimer 1+ and trimer 1+ peaks (a 
large blanker I pulse width, 6 µs, was used to view the trimer peak).  
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Sphingomyelin (731Da): sphingomyelin was purchased from Avanti Polar Lipids 
Inc. (Alabaster, AL) and dissolved into 50% formamide/water solution. It was further 
diluted by formamide to 2×10
-4
 mol/L. The solution was deposited on silicon wafer and 
vacuum dried. In order to get the peaks for polymer peaks, blanker I pulse width was set 
at a large value, 6 µs. Singly charged, dimer, trimer, tetramer, pentamer and hexamer 
peaks were observed (Figure 44).  A higher resolution mass spectrum was shown in.
 
Figure 44. (a):structure of sphingomyelin;(b): mass spectrum of sphingomyelin, 6 µs 
blanker I pulse width. The 1+, dimer 1+, trimer 1+, tetramer 1+, pentamer 1+ and 
hexamer 1+ peaks were observed.  
 
1,2-Dioleoyl-sn-glycero-3-phosphocholine (786Da): it was purchased from 
Sigma-Aldrich (St. Louis, MO) and dissolved in CHCl3 to make a 0.25 mol/L solution. 
The solution was deposited on a silicon wafer and air dried. Blanker I pulse width was 2 
µs (Figure 45). 
  70 
 
Figure 45.(a): structure of 1,2-Dioleoyl-sn-glycero-3-phosphocholine;(b): mass spectrum 
of 1,2-Dioleoyl-sn-glycero-3-phosphocholine, 2 µs blanker I pulse width. The 1+ peak 
was clearly observed.  
 
Cholesterol (386Da): it was dissolved in CHCl3 to make a 0.5 mol/L solution. 30 
µL of this solution was deposited on a silicon wafer and air dried. Blanker I pulse width 
was 5 µs. 
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Figure 46. (a): structure of cholesterol; (b): mass spectrum of cholesterol, 5 µs blanker I 
pulse width. The singly charged peak was clearly observed. 
 
4.3 Peptides 
Bradykinin (1060Da): amino acid sequence is Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-
Arg. Figure 47a shows a spectrum obtained by EDI (Asakawa et al. 2007). Singly 
charged molecular peak was observed.  
The sample in the MCI-TRIFT test was purchased from American Peptides 
(Sunnyvale, CA) and dissolved in deionized water to make a 0.005 M solution. The 
blanker I pulse width was 2 µs. The (M+H)
+
 peak and the (M+Na)
+
 peak were clearly 
observed (Figure 47b).   
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Figure 47. (a), mass spectrum of bradykinin obtained by EDI, [M+H]
+
 was observed, 
reprinted with permission from Asakawa et al. (2007), Copyright 2007 John Wiley & 
Sons, Ltd.; (b) mass spectrum of bradykinin (1060 Da) obtained by MCI-TRIFT. 2 µs 
blanker I pulse width. From the 22 Da mass difference between peaks A and B, A was 
assigned to(M+H)
+
 and B was assigned to (M+Na)
+
.The mass difference between B and 
C was 14 Da so C might be (M+Na-NH2)
+
. 
 
Angiotensin II (1046 Da): the amino acid sequence is Asp-Arg-Val-Tyr-Ile-His-
Pro-Phe. Figure 48a shows a mass spectrum acquired by EDI (Asakawa and Hiraoka 
2011). The [M+H]
+
 was observed.  
In the MCI-TRIFT test, the sample was purchased from Sigma-Aldrich (St. Louis, 
MO) and dissolved in deionized water to make a 5×10
-4 
mol/L solution. Blanker I pulse 
width was 2 µs. The (M+H)
+
 and (M+Na)
+
 peak were clearly observed (Figure 48b).  
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Figure 48. (a): mass spectrum of angiotensin II obtained by EDI (Asakawa and Hiraoka 
2011), [M+H]
+
 was observed, reprinted with permission from Asakawa and Hiraoka 
(2011), Copyright 2011 John Wiley & Sons, Ltd.; (b): mass spectrum of angiotensin II 
obtained by MCI-TRIFT. 2 µs blanker I pulse width. The mass difference between peaks 
A and B was 22 Da and so peak A was assigned to (M+H)
+
 and peak B was assigned to 
(M+Na)
+
 peaks. 
 
Peptide Mixture: a peptide mixture containing angiotensin II(1046Da), 
angiotensin I (1296 Da), substance P(1347 Da), bombesin (1619Da), ACTH clip 1-17 
(2093 Da), ACTH clip 18-39 (2465 Da) and somatostatin 28 (3147 Da) was bought from 
Bruker Company. A MALDI spectrum of this peptide mixture (refer to the peptide 
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calibration standard product manual, Bruker Company, USA) was shown in Figure 49a. 
Peaks for all the peptides in the mixture were observed.  
In the MCI-TRIFT test, the sample was dissolved in deionized water to make a 25 
µmol/L solution. The solution was deposited on silicon wafer and vacuum dried. Peaks 
corresponding to different peptides were obtained. Blanker I pulse width was 8 µs. The 
peaks of angiotensin I and substance P overlapped with each other due to a big blanker I 
pulse width (Figure 49).  
 
Figure 49. (a): MALDI spectrum of peptide calibration standard, reprinted from the 
product manual (Bruker Company, USA); (b): Mass spectrum of a peptide mixture 
acquired with MCI-TRIFT. 8 µs blanker I pulse width. Peaks for different peptides were 
observed.  
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4.4 Proteins 
Insulin (5808 Da): Asakawa et al. (Asakawa et al. 2007) obtained an insulin 
positive ion spectrum using water cluster impact. The singly and doubly charged peaks 
were observed (Figure 50a). 
In the MCI-TRIFT test, insulin (Sigma Aldrich, St. Louis, MO) was dissolved in 
formamide to make a 5×10
-5
 M solution. Blanker I pulse width was 5 µs. The singly 
charged and doubly charged peaks were observed (Figure 50b). The insulin chain A and 
B peaks were also observed.  
 
Figure 50. (a): mass spectrum of insulin obtained with water cluster impact by Asakawa 
et al. (Asakawa et al. 2007), singly and doubly charged peaks were observed, reprinted 
with permission from Asakawa et al. (2007), Copyright 2007 John Wiley & Sons, Ltd.; (b) 
mass spectrum of insulin obtained with MCI-TRIFT. 5 µs blanker I pulse width. The 
insulin 1+, 2+, 3+ peaks, chain A and B were also observed.  
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Lysozyme (14.3 kDa): a spectrum of lysozyme was acquired by Hiraoka, Mori, 
and Asakawa (Hiraoka, Mori, and Asakawa 2006) with water cluster impact. Singly 
(barely seen) and multiply charged peaks were observed (Figure 51a).  
In MCI-TRIFT, the lysozyme sample was dissolved in a 0.01 M HCl solution to 
make a concentration of 0.001 mol/L. Blanker I pulse width was 12 µs. The singly 
charged peak was barely seen. The doubly charged and triply charged peaks were 
observed (Figure 51b). 
 
Figure 51. (a): mass spectrum of lysozyme obtained by EDI, singly and multiply charged 
peaks were observed, singly charged peak was barely seen, reprinted with permission 
from Hiraoka, Mori, and Asakawa (2006), Copyright 2006 John Wiley & Sons, Ltd.; (b): 
mass spectrum of lysozyme obtained by MCI-TRIFT. The 1+ peak was barely observed 
which might be due to the detector sensitivity. The 2+ and 3+ peaks were clearly 
observed.  
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4.5 Oligonucleotides  
Typically, MALDI is used to detect oligonucleotides in the 10-50 base range, ESI 
is usually used for oligonucleotides with large number of bases detection. SIMS with 
atomic ion beam or cluster ion beam have not been proven to be effective in the detection 
of oligonucleotides. Here tests on oligonucleotides were done to demonstrate the 
capability of MCI.  
Oligo(dT)6mer (1763 Da): 10 µg of Oligo(dT)6mer was dissolved in 20 µL 
deionized water. The solution was deposited on silicon wafer and vacuum dried. Negative 
mode was used with sample voltage -3055 V. Source voltage was at -15 kV. Post 
acceleration was at +6 kV. Blanker I pulse width was 5 µs. A spectrum with positive 
mode was also obtained with lower S/N.  
 
Figure 52.Negative mass spectrum of Oligo(dT)6mer. 5 µs blanker I pulse width. A was 
the negatively charged molecular peak. B and C may be the fragments of (dT)6mer or the 
impurities of (dT)5mer and (dT)4mer. D may be negatively double charged molecular 
peak, or a fragment peak of (dT)6mer, or an impurity of (dT)3mer in the sample. 
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Oligo(dT)15mer (4501Da): 10 µg of oligo(dT)15mer was dissolved in 20 µL 
deionized water. The solution was deposited on silicon wafer and vacuum dried. Negative 
mode was used with sample voltage -3055 V. Source voltage was at -15 kV. Post 
acceleration was at +6 kV. Blanker I pulse width was 8 µs. The absence of fragment 
peaks and the high intensity of the 2- peak suggests that peak B and C in Figure 38 were 
probably the impurities and that peak D was the 2- species. 
 
Figure 53. Negative mass spectrum of Oligo(dT)15mer. 8 µs blanker I pulse width. The 
1- and 2- peaks were clearly observed.  
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4.6 Raw Salmon and Shrimp 
In order to test the capability of MCI-TRIFT to acquire a lipid spectrum from 
tissue sample, salmon and shrimp in a freshly prepared sushi purchased at a local grocery 
store was used. The edge of a glass slide was used to scrape small amounts of material off 
the sample surfaces and smear them onto silicon wafers. The samples were immediately 
placed in the instrument with no further sample processing.  The whole process took only 
ten minutes. 
The mass range from m/z 700 to 1050 is displayed. The lipid contents in the cells 
are mainly located in this mass range. The peak pattern of the salmon lipids acquired by 
MCI-TRIFT (Figure 54a) was very similar to that observed by Porcari et al. and had been 
assigned to triacylglycerols (TAGs) (Porcari et al. 2012) (Figure 54b). The peak pattern 
of the shrimp lipids (Figure 54c) obtained by MCI-TRFIT might be due to the 
assignments provided by Mika et al (Mika et al. 2013) (Figure 54d) acquired by MALDI-
TOF for Crangon crangon. 
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Figure 54. (a): mass spectrum of raw salmon obtained by MCI-TRIFT (1.04 m/z per bin, 
2 μs blanker I pulse width), majority of the lipid peaks locate at m/z 850-950; (b): mass 
spectrum of salmon obtained with easy ambient sonic-spray ionization mass spectrometry 
(EASI-MS) by Porcari et al. (Porcari et al. 2012), a similar lipid peaks range was 
observed, reprinted with permission from Porcari et al. (2012), Copyright 2012 The 
Royal Society of Chemistry; (c): mass spectrum of shrimp (1.23 m/z per bin, 2 μs blanker 
I pulse width) obtained by MCI-TRIFT, majority of the lipid peaks locate at m/z 700-850;  
(d): MALDI-TOF spectrum of Crangon crangon obtained by Mika et al. (Mika et al. 
2013) shows similar lipid peaks range.  
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CHAPTER 5 
ION IMAGING AND LATERAL RESOLUTION 
Besides the intact mass range, imaging resolution is another important parameter 
for an imaging technology to be useful. Imaging resolution determines the size  of 
biological features which can be resolved (e.g. sub-cellular imaging of single cancer cell 
in patient tissues). In the MCI-TRIFT, since it is an ion microscope imaging mass 
spectrometer, the imaging resolution is determined by the secondary ion optics.  
A 60× magnification of the sample ion image (~350 µm) was projected onto a 
position sensitive detector (micro-channel plates with phosphor screen). A Canon EOS 
camera was used with bulb mode to record the ion image on the back of the phosphor 
screen.  
Here various patterned peptide, lipid and protein samples were used to 
demonstrate the imaging resolution achievable with the MCI-TRIFT system. 
 
5.1 Bradykinin Imaging 
In order to test the imaging resolution, patterned samples with physical boundary 
were used here.   
 
5.1.1 Gold grid on Dry Bradykinin Layer 
The gold grid has a physical bar and hole (Figure 55). This is a common way used 
to generate a known pattern.   
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Figure 55. Optical image of the gold grid, 37 µm hole width, 25 µm bar width, 6 µm 
thickness (height).  
 
Sample preparation: bradykinin (American Peptide, Sunnyvale, CA) was 
dissolved in deionized water to make a 0.16 mol/L solution. 20 µL of the solution was 
deposited on indium foil and vacuum dried. A clean gold grid (hole width 37 µm, bar 
width 25 µm thickness (height) 6 µm) was then placed on top of the dried bradykinin 
layer and attached at the edges with carbon paint. The indium substrate with the dried 
bradykinin layer was rough (5~20 µm), and the gold grid appeared to be somewhat loose 
presumably with gaps, so that the topography (height difference between the sample 
surface and the gold grid surface) of this ion-imaging sample was worse than the grid 
height of 6 µm. 
In the imaging process, the blanker I pulse width was set to 8 µs. The blanker II 
pulse width was set to choose only the bradykinin peak. An ion image showed bright 
features in the holes where bradykinin was exposed to the primary cluster ion beam 
(Figure 56b). A gold peak was not observed. In order to generate a contrast pattern of the 
gold grid bar, the blanker II was chosen to select the low mass m/z ions from 0-250 Da. 
Both the gold grid bar and gold grid hole area were bright (Figure 56c). A line scan 
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across several bradykinin blocks in Figure 42b was done. The plot profile was obtained 
from ImageJ software. A 5 µm distance bar has been put on the plot profile to show the 
sharp trailing edge of each bradykinin block.  
 
Figure 56.(a): sample preparation scheme;(b): ion image of bradykinin (20 µL of 0.16 
mol/L on indium foil under a clean gold grid) (1.89 m/z per bin, 8 µs blanker I pulse 
width); (c): ion image of the contrast gold grid (m/z 0-250); (d):plot profile of the line 
scan at Figure 56b, 5 µm distance bar was placed on the plot; (e) and (f) are mass spectra 
for the corresponding ion image (Figure 56b, Figure 56c). The acquisition time of the 
mass spectrum in Figure 56e and of the bradykinin ion image in Figure 56b was 1.7 min.  
  84 
From Fig 56b, we can see there was a shadowing (~10 µm) from the gold grid on 
the bradykinin hole area. The boundary of the bradykinin ion image was blurred by 
different extraction efficiency due to the topography difference.  
 
5.1.2 Gold grid on Wet Bradykinin Solution 
In order to decrease the topography difference, a gold grid was put on top of a wet 
bradykinin solution. The capillary action helped to minimize the gap between the gold 
grid and sample surface. 10mg of bradykinin was dissolved in 50 µL deionized water to 
make a 0.19 mol/L solution.  ~0.3 µL of solution was deposited on silicon wafer. Clean 
gold grid was gently applied on top of the liquid. The gold grid was attached to the 
deposit by capillary action. The sample was air dried. 
In Figure 57, there was less shadowing (~2 µm) on the bradykinin block 
compared with the dry sample deposits. A line scan across the bright bradykinin block 
showed an imaging resolution of ~3 µm which is better than the imaging resolution 
obtained in the dry sample. 
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Figure 57.(a): a clean gold grid was put on top of a bradykinin solution;(b): bradykinin 
spectrum showing the signal to noise ratio;(c): spectrum obtained when the bradykinin 
ion window was selected by blanker II; (d): ion image corresponding to spectrum in 
Figure 57c, the gold grid hole area was brighter than the gold grid bar area;(e): the 
contrast gold grid ion image was obtained with the blanker II selecting low mass ion 
window; (f): a line scan across a bradykinin block demonstrated a resolution of ~3 µm. 
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5.1.3 Bradykinin Stripe Imaging 
In order to further minimize the topography issue (the gold grid has an intrinsic 
height of 6 µm), a patterned dry deposit on a silicon wafer without any gold grid on top 
was used. A microchannel was fabricated in PDMS [polydimethylsiloxane] on a silicon 
wafer using soft lithography (Figure 58a). The width of the microchannel was 94 µm. 
The channel was filled with 0.005 M bradykinin solution (in deionized water) and the 
solution was allowed to air dry.  Removal of the PDMS left a 94 µm wide stripe of solid 
bradykinin on the silicon surface. The microchannel here was used to put a physical 
boundary for the bradykinin deposit. In this way, a pattern was built up.  
The spectrum in Figure 58b shows the signal selected by blanker II, 47 - 72 µs 
after the 8 µs blanker I pulse; the bradykinin singly-charged peak was superimposed on a 
quasi-continuous background in a mass interval ~ 750 - 1550 Da.  This mass window was 
selected to allow evaluation of the background for ion yield determination. Figure 58c 
shows the CCD camera image for an acquisition time of 1 minute. An ion image of the 
bradykinin stripe shape was clearly seen.  A plot profile from a line scan over the edge of 
the channel (Figure 58d) was obtained from ImageJ software. It demonstrates a lateral 
resolution of about ~3 µm (Zhang, Franzreb, and Williams 2014). Using different lens 
settings it should be possible to improve spatial resolution to ~ 1 µm at the expense of 
transmission (Schueler 1992; Schueler 1990). 
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Figure 58. (a): Bradykinin stripes (yellow) formed inside 94 µm width microchannel on 
silicon; (b): Mass spectrum from bradykinin stripe within blanker II ion window 47 µs -
72 µs after the start of 8 µs blanker I pulse. 1.89 m/z per bin; (c): Ion image of micro-
channel for the selected ion window. Line scan position indicated; (d): Line scan across 
the micro-channel edge, a 3 µm bar was used to estimate the imaging resolution.  
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5.2 Peptide Mixture Imaging 
The peptide mixture sample discussed at Chapter 4 was used to do an imaging test. 
25 µmol/L solution was deposited on silicon wafer and vacuum dried. The gold grid was 
placed on top of the dry peptide deposit and attached at the edges with carbon paint. 
Blanker I pulse width was 8 µs. Blanker II was used to select the overlapped angiotensin 
I and substance P ion window. The pattern shown at Figure 59b matched with the gold 
grid pattern shown at Figure 59c. Please refer to Figure 61 for the detailed explanation of 
the bright circular feature in Figure 59b. 
 
Figure 59.(a):spectrum of peptide mixture (8 µs blanker I pulse width); (b): when the ion 
window of angiotensin I and substance P was selected, an ion image was obtained; (c):a 
contrast gold grid ion image was shown with low mass ion window selected. 
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5.3 Lipid Imaging 
A lipid ion image was obtained with L-α-phosphatidylcholine. A clean gold grid 
was dipped into the L-α-phosphatidylcholine solution. The gold grid was taken out and 
air dried. A bradykinin layer was deposited on the silicon wafer. The gold grid with L-α-
phosphatidylcholine was put on top of the bradykinin layer (Figure 60a). In the imaging 
process, when the blanker II was used to choose the L-α-phosphatidylcholine peak ion 
window, the gold grid was bright (Figure 60b). When the blanker II was used to choose 
the bradykinin ion window (Figure 60c), the tiny spots within the gold grid hole area 
were bright. Please refer to Figure 61 for the detailed explanation of the bright circular 
feature in Figure 60b and Figure 60c. 
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Figure 60. (a):sample preparation for L-α-phosphatidylcholine on grid and bradykinin 
underneath; (b):ion image when L-α-phosphatidylcholine single charged peak was 
selected; (c): ion image when bradykinin single charged peak was selected; (d): mass 
spectrum of L-α-phosphatidylcholine corresponding to ion image in Figure 46b; (e): mass 
spectrum of bradykinin corresponding to ion image in Figure 60c. 
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5.4 Protein Imaging 
1 µL of 0.03 mol/L insulin solution (in formamide) was deposited on a piece of a 
flat silicon wafer. A clean gold grid was gently put on top of the wet insulin solution. The 
capillary action helped in attaching the gold grid closely to the insulin solution. The 
sample was air dried. Figure 47a shows a mass spectrum of insulin 1+ and 2+ peaks with 
15 µs blanker I pulse width. Figure 47b shows a mass spectrum when blanker II was 
activated (141 µs- 158 µs delay with respect to the start of the blanker I pulse) to select 
the insulin single charged peak. A significant intensity of low m/z ions were observed 
even though blanker II was set to select only the insulin singly charged peak. An ion 
image of insulin (Figure 61c) was obtained corresponding to the mass spectrum in Figure 
61b.The image acquisition time was 1 min. A line scan across an insulin bright block 
demonstrated an imaging resolution of ~3 µm (Figure 61e).  
The insulin image has a pronounced bright feature that has also been seen in some 
other images (Figs. 59, 60). This feature may be associated with the intense flux of low-
mass ions that appears to be able to leak through blanker II even though the voltage is 
200 V.  Figure 61d shows a high resolution mass spectrum with 400 ns blanker I pulse 
width and with blanker II selected at the same time window as Figure 61b (i.e. to pass 
insulin 1+). Resolved low m/z ion peaks (H3O
+
, Na
+
, K
+
) were observed. These were the 
regular low m/z ions produced at the sample. Based on this, the bright circular artifact in 
Figure 61c may originate from these low m/z ions leaking through the closed blanker II, 
perhaps by scattering off the blanker plate.  
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Figure 61. (a): insulin mass spectrum showing 1+ and 2+ peaks (15 µs blanker I pulse 
width, 6.14 m/z per bin); (b): mass spectrum when only the insulin 1+ peak was selected 
(blanker II at 141 µs- 158 µs delay with respect to the start of the blanker I pulse, 9.45 
m/z per bin), but intense low m/z ions were observed; (c): ion image corresponding to the 
mass spectrum in Figure 61b, the bright circular artifact may originate from the low m/z 
ions leaking through blanker II; (d): 400 ns blanker I pulse width high resolution mass 
spectrum with the same blanker II window selected in Figure 61b showing the resolved 
peaks (H2O
+
, Na
+
, K
+
) for the leaking through light ions; (e): plot profile of a line scan 
(S/N is ~2) through an 70 µm insulin block in Figure 61c demonstrated a spatial 
resolution of ~3 µm.  
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CHAPTER 6 
USEFUL ION YIELD MEASUREMENTS 
In the 4
th
 and 5
th
 chapters, an intact mass range of several kDa and an imaging 
resolution of ~3 µm have been demonstrated. Another question that remains unknown is 
whether enough ion counts from a pixel (3×3 µm
2
) can be obtained in order to make a 
meaningful ion image. The concentration of biomolecules in the tissue or cell sample is 
limited. Useful ion yield (UY) is defined as the ion counts detected divided by the total 
number of molecules sputtered from the sample. This number determines the number of 
ion counts which can be obtained with a limited number of sample molecules. This 
number is important for us to know whether this MCI technology can deal with 
biomolecules in tissue samples.   
One problem with MCI-TRIFT that has been addressed in the previous chapters is 
the duty cycle. The secondary ions need to be pulsed for time of flight mass analysis. 
Only a small percentage of secondary ions can enter the secondary column. Most of them 
are blocked by the blanker I. Duty cycle (also called sampling efficiency) refers to the 
percentage of secondary ions going through the blanker I.  
The duty cycle problem can be eliminated if either the primary cluster ion beam 
can be pulsed, or the MCI source is coupled with a Cameca xf instrument which can 
operate with DC primary ion beam and DC secondary ion beam (a future plan). Since we 
are mostly interested on the optimal performance of the massive cluster ion beam, the 
useful ion yield numbers measured below were corrected for the duty cycle. These 
numbers give an idea of how many ion counts can be produced with the massive cluster 
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impact from a known quantity of sample molecules, regardless of the details of the mass 
spectrometer.  
Experiments have been designed to measure this UY number for a variety of 
species. The idea is to spot a known amount of sample molecules inside the field of view 
(FOV). Through counting the molecular ions at the detector, the useful ion yield number 
can be calculated. The field of view is ~350 µm. A spot size smaller than this must be 
generated.  
 
6.1 Useful Ion Yield Sample Preparation and Measurements 
Bradykinin was dissolved in water to make 0.005 mol/L and 0.0005 mol/L 
solutions. A fused silica capillary with 150 µm ID and 360 µm was used to make a small 
spot size. The polyimide layer of the fused silica capillary was burned off to reduce the 
outer diameter to ~300 µm. The capillary was inserted into a plastic pipette tip and sealed 
with an alcohol burner. The capillary was first rinsed with the sample solution.  The 
surface tension of water droplets on silicon wafer helped to constrain the spot size. The 
volume of liquid was calculated through the meniscus change in the capillary (Figure 
62a). A spot size of ~175 µm was determined in Figure 62b.  Multiple spots were 
deposited. A spectrum of bradykinin is shown (Figure 62b). At the end of the 
measurement, all the bradykinin deposit was removed by the MCI beam and no 
bradykinin peak was visible in the mass spectrum (Figure 62c).  
Individual drop sizes (~ 7-9 nL, ~ 0.5 mm length change) could not make a 
meniscus change that could be accurately measured. Multiple spots were used. The total 
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deposited volume was obtained from the total length change of the liquid meniscus in the 
capillary. The total counts obtained from multiple deposits were divided by the total 
number of molecules deposited to get the useful ion yield. Uncertainty in the total 
deposited volume measurement is estimated to be ~ 10-15 %. 
 
Figure 62.(a): sample preparation of tiny spots on silicon wafer;(b):optical images and 
mass spectra of bradykinin (~7 nL of 0.0005 mol/L, ~175 μm diameter) spotted on a 
silicon wafer (1.89 m/z per bin, 8 μs blanker I pulse width, CD #1). The mass spectrum 
was acquired during the first 30 s after switching on the massive cluster beam; (c):the 
mass spectrum was acquired in the 6 min - 7 min interval after switching on the beam. 
The optical image was taken after the measurement showing all the bradykinin deposit 
had been sputtered away.  
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Six other substances (rhodamine B, bradykinin, angiotensin II, sphingomyelin, L-
α-phosphatidylcholine and Insulin) were tested for their useful ion yield with contrast 
diaphragm #3 (the contrast diaphragm that gave ~3 µm spatial resolution in Chapter 5) 
and #1.   
Sample preparation: Rhodamine B (Sigma Aldrich, St. Louis, MO) was dissolved 
in deionized water to make a 1.0×10-4 M solution. Angiotensin II (Sigma Aldrich, St. 
Louis, MO) was dissolved in deionized water to make a 5×10
-4 
mol/L solution.  L-α-
phosphatidylcholine (from egg yolk) (Sigma Aldrich, St. Louis, MO) was dissolved in 
formamide to make a 1.8×10-4 M solution. Sphingomyelin (Avanti Polar Lipids Inc., 
Alabaster, AL) was first dissolved in 50% methanol/ in formamide solution, and then 
diluted by formamide to 2.0×10-4 M. Bradykinin was dissolved in deionized water to 
make 0.005 M and 0.0005 M solutions.  Insulin (Sigma Aldrich, St. Louis, MO) was 
dissolved in formamide to make a 5×10-5 M solution.   
Table 3 lists all the measurement parameters (blanker I pulse width, cycle period 
length, Blanker I transmission time, effective pulse width and duty cycle) for these 
compounds. Typical duty cycle ranged from 0.66%~4.8%. Since the compounds used in 
useful ion yield measurements were pure compounds, it was not necessary to have a high 
mass resolution. Blanker I pulse widths listed in Table 3 typically are 2-4 times bigger 
than the transmission time. A bigger blanker I pulse width lets more secondary ions go 
into the detector. 
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Table 3: Summary of experimental parameters (blanker I pulse width, cycle length, 
transmission time, effective pulse width and duty cycle) for rhodamine B, Irganox 1010, 
angiotensin II, bradykinin, sphingomyelin, L-α-phosphatidylcholine and Insulin. Duty 
cycle was calculated as the effective pulse width divided by the cycle length. 
Substance Molecular 
Weight 
Blanker I 
pulse 
width(µs) 
One cycle 
length 
(µs) 
Blanker I 
Transmission 
Time (µs) 
Effective 
Pulse 
Width (µs) 
Duty 
Cycle 
(%) 
Rhodamine B 
(without Cl-) 
443.5 Da 2 97 1.36 0.63 0.66 
Irganox 1010 1178 Da 6 138 2.1 3.9 2.8 
Angiotensin II 1046 Da 8 138 2.1 5.9 4.3 
Bradykinin 1060 Da 8 138 2.2 5.8 4.2 
Sphingomyelin 731 Da 4 138 1.76 2.24 1.6 
Sphingomyelin 
Dimer 1+ 
 4 138 2.49 1.51 1.1 
L-α-
phosphatidylcho
line 
758 Da 4 138 1.79 2.21 1.6 
Insulin (1+) 5808 Da 15 242 4.9 10.1 4.2 
Insulin (2+)  15 242 3.5 11.5 4.8 
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Table 4: Summary of useful ion yield for rhodamine B, angiotensin II, bradykinin, 
sphingomyelin, L-α-phosphatidylcholine, Insulin 1+ and 2+ for two different contrast 
diaphragm sizes (CD1 and CD3). Numbers marked as * represent the useful ion yield 
obtained when the capillary was near the end of its lifetime. 
Substance Nominal 
Mass 
Useful Ion Yield (×10
-5
) with sampling efficiency 
corrected 
Contrast Diaphragm #1 
(Diameter: 2.1 mm) 
Contrast Diaphragm #3 
(Diameter: 0.21 mm) 
Rhodamine B 
(without Cl-) 
443.5 Da 20;  16 9.8 
 
Irganox 1010 1178 Da 2.7 N/A 
Angiotensin II 1046 Da N/A 1.8 
Bradykinin 1060 Da 2.8; 2.5; 3.9 2.3; 1.9 
Sphingomyelin 731 Da 2.9 1.3 
Sphingomyelin 
dimer 1+ 
 0.32 0.33 
L-α-
phosphatidylcholine 
758 Da 2.7; 2.2; 1.3* 1.4; 1.2* 
Insulin (1+) 5808 Da 1.1; 1.1; 0.70 0.14 
Insulin (2+)  0.91; 0.80; 0.35 0.010 
  99 
               Table 4 summarizes the useful ion yields of rhodamine B, irganox 1010, 
angiotensin II, bradykinin, sphingomyelin, sphingomyelin dimer 1+, L-α-
phosphatidylcholine, insulin1+ and insulin 2+.  
The useful ion yield numbers in table 4 have been corrected for the duty cycle. 
They do not reflect the useful ion yield that can be obtained in this MCI-TRIFT 
instrument (continuous primary ion beam and pulsed secondary ion beam). They do 
represent the useful ion yield that could be achieved when either the primary ion beam is 
pulsed or the secondary ion beam is continuous in imaging.  
The useful ion yield of rhodamine B was larger compared with other compounds 
because rhodamine B (without Cl
-
) is a pre-formed ion with a quaternary ammonium 
center. The useful ion yield of insulin is at 10
-6
 range. With higher molecular weight, it 
has smaller detection efficiency and maybe more vulnerable to fragmentation. 
The useful ion yields for other compounds (peptides, lipids, organic molecules) 
are in the 1-3×10
-5
 range. What do these useful ion yield numbers mean? For example, 
the 3×3 µm
2
 cell membrane area of a lipid bilayer has 2.6×10
7
 lipid molecules (Nagle and 
Tristram-Nagle 2000). Phosphatidylcholine (PC), phosphatidylethanolamine (PE) and 
sphingomyelin (Sph) constitute ~40%, ~20% and ~10% in eukaryotic plasma membrane 
lipids (OPM database, University of Michigan). A useful ion yield of 1×10
-5 
and 10% 
lipid component can give ~26 counts/pixel. The statistical S/N is ~5 which is enough to 
make a useful ion image.  If we have unit mass resolution for imaging, for lipids at 700-
800 Da, the 
12
Cpeak is only 60% of the total. But still we can get ~16 counts/pixel under 
the same assumption, the statistical S/N is ~4 which still can produce a useful ion image. 
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Typically, a capillary can only be used for 2-3 weeks before replacement. In a 
dead capillary, the capillary inner space has been blocked by crystals from solution. 
Different stages of the capillary had different flow rate. According to the experiment 
done by Stimpson and Evans (1978), smaller flow rates resulted in more low mass/charge 
ions, thus heavier damage to the sample materials. A comparison between a fresh new 
capillary and a capillary being used for two weeks was done for the L-α-
phosphatidylcholine. The number marked as * refers to the useful ion yield when the 
capillary was near the end of its lifetime. The difference of UY was within a factor of 2.  
There are several contrast diaphragm (CD) sizes available in the TRIFT. The 
purpose of the CD is to limit the initial angular and energy distribution of the secondary 
ions coming out of the sample surface. The influence of the CD size on the useful ion 
yield has been investigated between CD1 (2.1 mm diameter) and CD3 (0.21 mm). The 
area of the CD aperture decreases 100 times from CD1 to CD3. But the factor of useful 
ion yield drops is much smaller, about a factor of ~2 for lipids and peptides and ~7 for 
insulin. This indicates that the beam crossover is not much bigger than the CD3 diameter. 
Useful ion yield is an important parameter determining whether an imaging 
resolution is meaningful. But up to now, there is not much research on the useful ion 
yield for MALDI or DESI.  
            Vickerman and colleagues et al. have estimated useful ion yield for 10keV Ar1000
+
 
and H2O 1000
+
 ion beams on angiotensin II deposits. From 1 µm
2
×10 nm volume, they 
estimated that 1 ion count and 6 ion counts could be obtained for 10keV Ar1000
+
 and H2O 
1000
+
 ion beam. The authors used a sputter yield number from C60 sputtering on a sugar 
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sample (Cheng, Wucher, and Winograd 2006). Taking their assumption that a 1  μm2 ×10 
nm volume of angiotensin II has 10
7
 molecules, in our case, the total counts of 
angiotensin II molecular ions (with duty cycle corrected) would be ~180 counts.  There is 
a significant improvement on the useful ion yield for massive cluster ions compared with 
Ar1000
+
 and H2O 1000
+
 ions.  
Gebhardt et al. used a neutral SO2 clusters beam generated from supersonic 
expansion to desorb and ionize sample molecules (Gebhardt et al. 2009).  An ionization 
probability test was done (Lee et al. 2013). Since the primary beam is a neutral beam, the 
sample stage current can be used to monitor the secondary ions leaving the sample 
surface. The author assumed that all the charge desorbed was attributed to the 
biomolecules (angiotensin II). In this way they got a useful ion yield of 10
-2
~10
-3
. If we 
assume a 10% overall transmission and detection efficiency in our case, their useful ion 
yield number is about 1-2 orders of magnitude greater than ours. It would be good if they 
can measure the useful ion yield from the ion counts of a mass resolved peak in the future. 
 
6.2 Sputter Rate Measurement. 
A sputter rate measurement was done to estimate how fast the MCI beam can 
sputter the sample. An organic delta layer sample (Irganox 1010, Irganox 3114) was 
donated by Dr. Ian Gilmore at NPL. This sample was constituted by two 47.5 nm and 
three 95 nm thickness irganox 1010 layers interspersed with four 2.5 nm layers of 
irganox 3114 (Figure 63). By measuring the time needed to sputter through this 390 nm 
thick delta layer sample, the sputter rate can be calculated.  
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Figure 63: Structure of the irganox delta layer sample (left). Optical image of the sample 
before the measurement showing the interference color (middle). An aluminum foil with 
a hole was put on the sample to limit the area being sputtered. Optical image of the 
sample after the measurement (right) showing that the open irganox area had been 
completely sputtered away by the massive cluster ion beam. The color transitions at three 
edges of the cleaned area indicated an angle of the primary ion beam sputtering the 
sample surface. 
 
When the source voltage was at -10 kV, the whole process took 40 min 
corresponding to a sputter rate of ~10 nm/min. When the source voltage was improved to 
-12 kV, the whole process took 18 min corresponding to ~20 nm/min. The reason for the 
sputter rate increase probably was due to the increasing primary cluster ion beam current, 
or the cluster distribution change. Since the sample stage current cannot be monitored, it 
was not clear which factor contributed to the sputter rate change. 
In microprobe ion imaging mode, the primary current is limited by the resolution 
required. Higher current will defocus the primary ion beam making the resolution poorer. 
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But this problem does not exist in microscope ion imaging mode since the imaging 
resolution is determined by the secondary ion optics. Thus significantly higher sputter 
rates can be used in the MCI-TRIFT. A fast measurement can be crucial in some 
applications, e.g. clinical application.  
 
6.3 Preliminary Tests on Cell Lipids with MCI-TRIFT 
Three types of breast cell lines were used: (1), MCF 10A, a breast non-cancer  
cell line; (2), MDA-MD-468, a breast cancer cell line; (3), MDA-MB-231, another type 
of breast cancer cell line.  The sample preparation was the same for these three types of 
cells. Here are the detailed steps (provided by Seron Eaton, Biodesign Institute, Arizona 
State University): (1). Cells were grown through log phase to ~80% confluency for 
experimental collection; (2). Cells were washed 2 times with PBS; (3). Trypsin was 
added to strip cells from the dish wall and cells were incubated at 37
o
C for 10-20 minutes; 
(4). Growth media was added to neutralize trypsin; (5). Cells number were counted; (6). 
Necessary amount of cells were aliquoted for the experiment. A density of 13.3×10
6
 
cells/ml (for 40,000 cells in 3 µl) was needed. A solution of 60µl of cells for spotting was 
made. 8×10
5
 cells were pipetted into a 1.5 ml Eppendorf tube; (7). The cell solution was 
centrifuged at 550 g for 5 minutes to pellet cells; (8). Supernatant was aspirated and 0.5 
ml of PBS was added to wash the cells; (9). The cells were centrifuged again and 
supernatant was aspirated; (10). Cell pellet was resuspended in 60 µl of PBS; (11). Cells 
were spotted onto prepared slides with 3 µl spots with 40,000 cells/spot; (12). Spots were 
allowed to dry and ready for analysis.  
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Multiple spectra of each cell sample were taken. A typical spectrum of each 
sample was chosen for comparison (Figure 64). 
 
Figure 64. Lipid patterns of (a) MCF 10A (a normal breast cell line), (b) MDA-MB-468 
(a breast cancer cell line), (c) MDA-MB-231 (another type of breast cancer cell line). 2 
µs blanker I pulse width. 
  105 
All the mass spectra for each sample were put together in Figure 65 to show the 
reproducibility of the patterns. 
MCF 10A: normal breast cells
MDA-MB-468, 
breast cancer cells
MDA-MB-231, 
breast cancer cells
Figure 65. All the mass spectra obtained for three different types of cells. The mass range 
displayed in all the spectra was the same, 700-900 Da. 2 µs Blanker I pulse width. The 
relative peak intensity patterns were different between these three cell lines. 
 
In Figure 65, the differences in the peak patterns between the normal cell line and 
the cancer cell lines can be observed. Furthermore, the ion counts number for different 
lipid domains (m/z 728, 744, 759, 772, 786, 801, 812, 838) were recorded to do 
quantitative calculation. Each domain could contain multiple lipid peaks. Since the mass 
resolving power is not enough in this MCI-TRIFT, each lipid domain was treated as a 
  106 
lipid peak for imaging. The identity of each lipid peak cannot be identified currently. The 
peak assignments for MDA-MB-231 can refer to table 1 reported by Chughtai et al. 
(Chughtai et al. 2013). Future improvement on the instrument is required in order to 
resolve single lipid peaks. For each spectrum, the ion counts number for m/z 786 was set 
as 100%, the relative intensity of other lipid domains were referred to this m/z. The 
relative intensity for each lipid domain was plotted at Figure 66. The error bar is the 
standard deviation of the mean multiplied by student factor at 95% confidence. Different 
expression intensity was observed between the cancer cells and normal cells at lipid 
domains at m/z 728 and 812.  
 
Figure 66: The relative intensity for the normal breast cells and two types of breast cancer 
cells for eight different lipid domains (m/z 728, 744, 759, 772, 786, 801, 812, 838). The 
ion counts number for m/z 786 was set as 100%, the relative intensity of other lipid 
domains were normalized to this m/z. The error bar is the standard deviation of the mean 
multiplied by student factor at 95% confidence. Different expressions have been observed 
between the cancer cells and normal cells at lipid domains of m/z 728 and 812. 
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6.4 MCI-Cameca xf  
The useful ion yield numbers reported above have been corrected by the duty 
cycle. The duty cycle is ~0.1% for lipid samples in Figure 54, 55. With the current MCI-
TRIFT instrument, only 0.3 count/pixel can be obtained from a cell assuming the cell 
membrane is constituted by a single 100% lipid content. This cannot generate a usable 
ion image. How can we eliminate the duty cycle issue? One straightforward method is to 
pulse the primary cluster ion beam. This is feasible, but it will reduce the primary cluster 
ion beam current at the target. This will prolong the measurement time which may not be 
acceptable in clinical application. Another idea is to couple the MCI source to a Cameca 
xf instrument (Figure 67). It also has ion microscope imaging capability. The mass 
analyzer is the magnetic sector. It can do ion microscope imaging with a few µm 
resolution. A DC primary cluster ion beam and a DC secondary ion beam can be used. 
The mass range for the current instrument is ~300 Da. With the sample stage voltage 
decreased from 10 kV to 3 kV (similar to TRIFT’s sample voltage), the mass range can 
go up to 1 kDa which is sufficient for lipid imaging. Better mass resolution is achievable 
~1000 (Peaks with more than 1Da difference can be resolved). This may be an ideal mass 
spectrometer for imaging with the glycerol massive cluster ion source.  
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Figure 67. The MCI source is coupled to Cameca xf instrument. Magnetic sector is used 
as mass analyzer. DC primary ion beam and DC secondary ion beam can be achieved 
without the duty cycle issue. Ion microscope imaging with a few µm and higher mass 
resolving power (lipid peaks with more than 1 Da mass difference can be resolved) are 
available.  
 
6.5 Optimization of MCI Useful Ion Yield 
In Figure 23, Stimpson et al. demonstrated a huge initial glycerol molecular ions 
emission (90% of the particle flux is low m/z ions). This light component damages the 
sample molecules at the surface and underneath. Lower temperature and flow rate can 
increase the percentage of this molecular ion emission. In order to improve the useful ion 
yield, we need to improve the percentage of heavier cluster ions (by improving the 
temperature at the capillary) and filter the low mass/charge ions. It should be noted that 
the glycerol cluster ion distribution might be different in our system compared to 
Stimpson’s. Ammonium acetate was used instead of the NaI. The capillary diameter is 
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also different. But Fujiwara has seen a similar low mass component with electrosprayed 
ionic liquid (Fujiwara et al. 2011).  
             There are multiple ways to filter the low m/z ions. First idea is to use two 
blankers in series. The first blanker can pulse the cluster ion beam to let a tiny pulse 
width through. At an appropriate distance away, the second blanker can choose the 
mass/charge window we want to go to the sample surface.  
             A selective cluster ion gun was designed and made. The scheme and optical 
image are shown below (Figure. 68, 69). There is an immersion lens in front of the 
capillary. It is used to focus the diverging cluster ion beam to improve the current at the 
sample stage. A steerer plate was designed after the immersion lens to deflect an off-axis 
beam back to the central axis. The first blanker (blanker III) is located after the steerer 
plate. The second blanker plate (blanker IV) is 18cm away from the first blanker. Both of 
these two blankers are operated with a 200V pulse. The time delay between the two 
blankers determines the mass/charge ion window going through.  
 
Figure 68: Scheme of a selective cluster ion gun. Two blankers (blanker III, IV) together 
can pulse the primary ion beam and select a mass/charge ion window going through. 
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Figure 69. Images of the selective cluster ion gun. The whole assembly (left) with first 
blanker at the bottom, second blanker at the top and four BNC cables to supply voltages 
to steerer plates and two blankers. MCI source and immersion lens (right). The middle 
electrode in immersion lens is applied with a negative 6~7 kV. 
 
            Another idea is to use magnetic deflection. Different mass/charge ions have 
different trajectories in a magnetic field. With an aperture at the exit of the magnetic field, 
certain m/z ions window can be selected or low m/z species can be rejected. 
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CHAPTER 7 
CONCLUSIONS 
In this thesis, a new imaging mass spectrometry technique was introduced. A 
massive cluster primary ion source was coupled to a time of flight ion microscope 
imaging mass spectrometer (TRIFT). The ion microscope imaging capability of the 
TRIFT does not require the primary MCI ion source to be focused which is difficult to do. 
The key parameters for an imaging mass spectrometry technology have been studied, e.g. 
intact mass range, imaging resolution and useful ion yield.  
A spatial resolution of ~3 µm, which is sufficient for sub-cellular imaging, has 
been demonstrated. Intact mass range of sputtering and ionizing molecules can go up to 
several kDa (up to lysozyme so far). This intact mass range can cover lipids, peptides and 
small proteins. The useful ion yields of lipids, peptides are within ~1-2×10
-5
. A 3×3 
µm
2
pure lipid bilayer can produce 260 counts/pixel with a 1×10
-5
 useful ion yield. This 
count number is enough to produce a useful ion image. Sputter rate was 20 nm/min when 
the source voltage was at -12kV. There is more space to improve the sputter rate without 
degrading the spatial resolution. Fast measurement, typical spectrum/image acquisition 
time ranges from a few seconds to minutes. This may be crucial in clinical application 
where fast measurements are required. The MCI source is cheap and easy to build. 
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Figure A.1. Schematic of Electrospray Reservoir 
 
 
 
 
 
 
 
 
  
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure A.2.  Schematic of MCI source flange  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure  A.3. Schematic of Extraction Electrode 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
